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B. Pharm., Kathmandu University, 2011 
 
 
ABSTRACT 
Objectives: Patients who use substances or those who are on opioid maintenance therapy 
could be at risk of inadequate nutrition. These inadequacies could translate to adverse 
outcomes during pregnancy. The objective of this study was to determine differences in 
dietary macro and micronutrient intake in pregnant women on OMT compared to healthy 
controls.  
Methods: Participants from a parent prospective cohort study “ENRICH” were classified 
into two groups: OMT users and healthy controls. Inclusion into the nutritional analysis 
was based on eligibility criteria of completion of food frequency questionnaire 
administered during hospital stay after delivery, absence of heavy drinking and adequate 
energy intake. Crude differences in energy, macro (carbohydrate, protein and total fat) 
and micronutrient (vitamin A, B1, B2, B6, B12, C, D, E, beta-carotenes, folate, iron and 
choline) intake between the study groups were compared using student’s t-test which was 
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repeated after adjustment by total energy intake. To control for multiple comparisons 
MANOVA was used. Multivariate regression was used to control for confounders. 
Results: A total of 54 subjects (34 OMT and 20 controls) were included in the nutritional 
analyses. No significant effect of OMT status on energy intake was observed. It was 
observed that OMT group had lower energy adjusted protein intake (p=0.03). Analysis of 
the dietary micronutrient intake showed that the subjects on OMT had significantly lower 
Vitamin E (-0.9a-TE/1000Kcal/day, 95%CI:-1.8, 0.1, p=0.03) and folate (-45.9 
DFE/1000Kcal/day, 95%CI:-87.1,-4.6, p=0.03) intake compared to controls after 
controlling for marital status, insurance type, age and BMI. There was a significant effect 
of ethnicity on energy-adjusted carbohydrate intake (p=0.02) and employment (p<0.01) 
on energy-adjusted protein intake after controlling covariates. It was observed that diet 
alone was not able to meet the requirements of several micronutrients in both the OMT 
and control group. 
Conclusion: It was observed that pregnant women on OMT had lower intake of several 
micronutrients compared to healthy controls which could lead to adverse pregnancy 
outcomes. The results of this study reinforces the requirement of micronutrient 
supplementation during pregnancy. Future studies should focus on investigating the 
effect of these differences in pregnancy outcomes and implement policies to promote 
healthy diet. 
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CHAPTER ONE: INTRODUCTION 
Background  
There is an epidemic of illicit drug use in the United States. In 2013, a national survey 
reported that there were 22.4 million adults in the U.S. who used illicit drugs1. There has 
been a steady increase in non-medical use of opioids over the last few decades which has 
become a significant concern for public health. The same survey in 2013 showed that the 
prevalence of opioid use among pregnant women aged 15 to 44 was approximately 5.4%. 
Some authorities consider that these estimates are modest due to underreporting of 
substance abuse in pregnancy. Still, the prevalence of illicit drug use poses a significant 
risk to the health of the mother and the growing fetus. 
The management of opioid addiction falls onto physiological and social interventions 2. 
Opioid maintenance therapy is the management of opioid dependence using 
pharmacological treatment to stabilize the physiologic dependence on harmful drugs3. 
The use of methadone and buprenorphine among other drugs have been shown to be 
effective for the treatment of opioid addiction 4,5. Studies have revealed that treatment 
with opioids agonists (methadone) /mixed agonist-antagonist opioid receptor modulator 
(buprenorphine) along with social intervention increase the likelihood of treatment 
success and minimization of relapse4. The treatment, however, is not without its side-
effects. In pregnant women treatment with methadone has been extensively studied 6-8. Its 
use is associated with neonatal abstinence syndrome9. A  few studies also report health 
complications such as low birth-weight  to be associated with opioid maintenance therapy 
(OMT) 10,11. These effects are moderate compared to the impact of use of other opioids 
and illicit drugs 11,12. Hence, methadone and buprenorphine have been recommended as 
an effective therapy for the management of opioid dependence.  
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There are several explanations of the effects of opioid abuse and OMT on pregnancy 
outcomes. There are actual physiological mechanisms of opioid that affect the 
neurotransmitters 13 that regulate neurologic and physiologic development in the fetus. 
Other reason could be a possible effect on absorption of nutrients due to opioids 14. 
Studies also show that socio-demographic reasons could lead to adverse pregnancy 
outcomes in opioid-addicted pregnant women 15. Concomitant use of alcohol and tobacco 
among other substances has also been widely reported to be associated with adverse 
pregnancy outcomes such as low birth weight and fetal alcohol syndrome 16-18. The 
complex nature of health behaviors related to opioid use, socio-demographic condition of 
the opioid using population, underlying diseases and, the nutrition affects the fetus and 
the mother in several ways. Singular intervention through OMT is almost never sufficient 
to mitigate the effects of opioid abuse and promote remission. Interventions such as 
social support, guidance, prenatal health checkups and adequate nutrition along with 
OMT are expected to promote good health in the fetus and the mother. 
Nutrition during pregnancy and nutrition status of pregnant women on opioid 
maintenance therapy 
Pregnancy is an important time for the development of the fetus. Adequate energy intake 
during the pregnancy along with micronutrients has been shown to decrease the 
probability of low birth weight (LBW) infant 19-21. LBW has been shown to be associated 
with infant mortality, respiratory disorders and developmental metabolic problems in 
future 22,23. The importance of good diet in pregnancy-related outcomes have been shown 
by several studies using dietary patterns and nutrient group analysis. Studies that analyze 
the association between dietary patterns around pregnancy and pregnancy outcomes 
reveal that food groups that had high energy, low nutrient density, high saturated and 
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trans-fats were associated with lower birth sizes. The converse, that is, nutrient dense 
food with fruits, vegetables, and whole grains were associated with positive pregnancy 
outcomes 24-28. However, there are inconsistencies with the associations of pregnancy 
outcome with dietary patterns, as some studies have shown an association of pregnancy 
outcomes with socio-demographic characters 29-31. 
Deficiencies of vitamins have been associated with adverse pregnancy outcomes 
regarding growth of the fetus, skeletal development, and future childhood development 
32-34. Apart from the studies that primarily focus on folic acid with iron supplementation 
and vitamin D on birth outcomes, there are a few studies that highlight the importance of 
B vitamins. A review by Allen (2005) states that deficiency of thiamin, riboflavin, folate 
or vitamin B12 is related to elevated levels of homocysteine in blood, which in turn was 
related to adverse pregnancy outcomes 34-36. There are several dietary intake 
recommendations that provide specific information on the intake of vitamins and 
minerals which are considered essential for the development of the fetus during 
pregnancy 37-42. Micronutrients such as folic acid, iron, zinc, magnesium, calcium, and 
several vitamins are necessary for proper growth and development of the fetus 43,44. 
Supplementation of micronutrients is considered important and widely recommended. 
However, some authors also state that requirements of some of the vitamins and minerals 
are usually met in healthy pregnancies through regular diet and changes is physiological 
mechanisms 37. However, it is essential to focus on having a healthy diet during 
pregnancy. Particular emphasis has been made on supplementation of folic acid for the 
prevention of neural tube defects (NTDs) 33,43. Thus, concerning the importance of 
micronutrients in diet, our focus is on vitamin A, carotenoids, thiamin (B1), riboflavin 
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(B2), vitamin C, vitamin D, vitamin E, folate, and iron intake in pregnancy. The 
following table shows deficiency of several vitamins and their effect on maternal and 
fetal health. 
Table 1: Micronutrient deficiency and associated maternal-fetal health outcomes 
Micronutrient deficiency Maternal health outcome Fetal health outcome 
Vitamin A Maternal anemia45 Preterm delivery45 
Vitamin B12 and Folate Anemia, weight loss Neural tube defects, small 
for gestational age birth, 
pre-eclampsia33,36,43 
Vitamin D Bone loss, subclinical 
myopathy, risk of pre-
eclampsia46  
Lower bone mass, risk of 
future osteoporosis47 
Vitamin E - Miscarriage48 
Iron Iron deficiency anemia32 Pre-term delivery 32, iron 
deficiency anemia if 
delivery is preterm 
Choline Liver and neurological 
diseases 49 
Risk of neural tube defects50 
 
Significance 
Heroin and other opioid users are associated with neglect for their physical nutritional 
and social care51. It is often coupled with risk of criminal activities and prevalence of 
infectious diseases in the patients. Prevalence of opioid use in pregnant women and the 
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association of adverse outcomes related to opioid abuse in pregnancy demonstrates the 
need of effective interventions to minimize adverse pregnancy outcomes in those 
populations1. OMT has been established as an effective therapy for the treatment and 
maintenance of opioid addiction in pregnant women 6. Compared to non-OMT related 
methods of addiction therapy, methadone maintenance therapy has been shown to be 
significantly better in retaining patients in treatment and suppressing heroin use 52. OMT 
is also associated with better adherence to prenatal care, decreased risk of being 
incarcerated and decreased risk of acquiring blood borne infections associated with illicit 
drug use52.  It should be considered that OMT, as all opioids, have some adverse effects 
on maternal and child health such as low birth weight and neonatal abstinence 
syndrome.9,11,53. It is important to consider these adverse outcomes associated with opioid 
use in pregnancy. Interventions consisting of regular prenatal care, social support and 
other medical treatments should be provided to such population. 
Figure 1 highlights the association between maternal factors, intervention and pregnancy 
outcomes. We can observe that there are several factors that come into play that lead to a 
healthy pregnancy outcome or an adverse even. Factors such as pregnant mother’s age, 
her immediate socio-demographic surroundings and her health and medical conditions 
could play a significant role in outcome of that pregnancy. To promote a healthy 
pregnancy interventions such as regular prenatal care, healthy diet, multivitamin 
supplementation, social support, management of opioid abuse could be necessary,
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Figure 1: Relationship between maternal factors, interventions and pregnancy outcomes 
 
Pregnant women have greater than average requirement of calories and nutrition for the 
development of the fetus and to develop stores of lactation54. Adequate nutrition, 
balanced in calories and micronutrients, which is based on recommended dietary 
allowances has been shown to be associated with positive outcomes in pregnancy. 
Studies consistently show the benefits of adequate weight gain and supplementation of 
diet with multivitamins and folic acid55,56. Opioid dependent pregnant women are already 
under the stress of the drugs they are taking. Thus, it is imperative that proper nutrition be 
a part of OMT in pregnant women. 
There have been a few studies about nutrition in subjects undergoing OMT in non-
pregnant population. These studies showed that subjects in the opioid maintenance 
program had higher carbohydrate intake and poor micronutrient status57,58. Our search of 
the literature resulted in just a single study on nutrition status performed on opioid 
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dependent pregnant women. The pilot study on pregnant women on OMT (n=22) and 
non-OMT pregnant women (n=119) showed that pregnant women on OMT had 
significantly higher energy intake which after adjusting for confounders was 
approximately 34% greater than the energy intake of controls59. The study also analyzed 
nutritional biomarkers and found that after adjustment serum homocysteine was higher 
and serum carotenoids were lower in OMT group as compared to controls. 
The results of the studies on non-pregnant opioid dependent population and the pilot 
study on pregnant women on OMT suggest that pregnant women on OMT may be at high 
risk of poor nutrition. However, the pilot study on pregnant women on OMT had a small 
population size and did not evaluate the outcomes related to pregnancy. Thus the purpose 
of our project is to examine the differences in nutritional status of pregnant women on 
OMT with non-opioid using population. Future direction of our research could be to 
examine the association of these different pregnancy outcomes such as pre-term delivery 
and birth weight. 
The result from our study is expected to confirm that there are nutritional differences in 
pregnant women on OMT as compared to controls. We expect the result to be in 
concordance with the studies in non-pregnant opioid using population. Such result would 
mean that the OMT population in our study would have higher energy intake and poor 
micronutrient status. This would place these women at a higher risk of adverse pregnancy 
outcomes. The result from our study is expected to be used to formulate interventions 
regarding dietary intake in pregnant women on OMT. In conjugation with OMT and 
prenatal care, proper nutrition can help minimize adverse pregnancy outcomes and 
promote proper growth and development of the fetus. 
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Study hypothesis and specific aims 
Specific Aim I: To determine the differences in energy intake and the sources of energy 
(carbohydrates, fats, proteins) in pregnant women on OMT compared to non-opioid using 
pregnant women. 
Research Hypothesis I: We hypothesize that there will be differences in energy intake in 
pregnant women on OMT compared to non-opioid using pregnant women. 
Specific Aim II: To determine the differences in dietary vitamin A, B1, B2, B6, B12, C, 
D, E, and beta-carotenes intake in pregnant women on OMT compared to non-opioid 
using pregnant women. 
Research Hypothesis II: We hypothesize there will be difference in dietary intake of 
vitamins in pregnant women on OMT compared to non-opioid using pregnant women. 
Specific Aim III: To determine the differences in dietary iron, folate and choline intake 
in pregnant women on OMT compared to non-opioid using pregnant women.  
Research Hypothesis III: We hypothesize that there will be differences in dietary folate, 
iron and choline intake in pregnant women on OMT compared to non-opioid using 
pregnant women. 
Sub-aim for Specific Aims I, II and II 
To determine the effect of socio-demographic characteristics on energy and micronutrient 
intake. 
Specific Aim IV: To assess if the participants in our study meet the estimated average 
requirements based on their diet and micronutrient supplements. 
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CHAPTER TWO: LITERATURE REVIEW 
Epidemiology of drug abuse in United States 
The 2013 report on substance use from the National Survey on Drug Use and Health 
stated that an estimated 22.4 million adults older than 18 years used illicit drugs in the 
United States 1. Illicit drugs included marijuana, cocaine, inhalants, hallucinogens, heroin 
or prescription drugs (non-medical usage). This estimate shows that approximately 9% of 
the American population used illicit drugs of which a significant portion were marijuana 
users (7.6%) and prescription drug abusers (2.5%). There has been a steady rise in drug 
abuse over the past five decades with a significant rise in abuse of therapeutic opioids. 
Hydrocodone topped all prescriptions with 136.7 million prescriptions in 2011.  
The exponential increase in the abuse of illicit drugs constitutes an important public 
health problem in the US. Approximately 80% of the 43,982 overdose related deaths in 
the US in 2013 were unintentional 60. Also, the economic impact of drug abuse is 
significant with an estimated cost of $55.7 billion in 2007. Lost productivity accounted 
for approximately 46% of the above cost and 45% was related to healthcare cost 61.  
Illicit drugs use in pregnant women 
Prevalence of substance abuse is difficult to establish particularly due to inaccuracies of 
self-report. Thus, the data regarding drug abuse in pregnant women varies according to 
the population sampled, the method of test used, screening period and sampling 
(community population or targeted population). Social stigma, fear and embarrassment 
could prevent women from disclosing drug abuse. The fear of legal and social action 
could also prevent pregnant women from disclosing drug use thus delaying care. These 
various factors combined with the inaccuracies of self-report makes it difficult to get 
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proper estimates of drug abuse during pregnancy. We can consider current estimates to be 
low because of the above reasons which lead to under-reporting.  
The National Survey on Drug Use and Health is an annual survey which provides 
information on use of illicit drugs, alcohol and tobacco on state and national level 1. 
Current report (combined 2012-2013 data) states that illegal drug use in pregnant women 
aged 15 to 44 was approximately 5.4 % which is lower than the rate in non-pregnant 
women (11.4%). There has not been a significant increase in illicit drug use over the past 
couple of years; 2007 - 2009 (5.1%) and 2009-2010 (4.4%). The prevalence of illicit drug 
use is lower in the third trimester (2.4%) versus the first (9.0%) and the second (4.8%) 
trimester. The distribution of the prevalence of drug abuse over the age of pregnant 
women showed that the highest prevalence was for the age group 15-17 years (14.6%) 
followed by the age group 18 to 25 years (8.6%) and the age group 26-44 years (3.2%). 
Methadone and Buprenorphine for treatment of opioid abuse in pregnant women 
Opioid dependence has been defined as a “physiological disease characterized by a 
permanent metabolic deficiency” by Dole and Nyswander 3. According to their treatment 
principle of managing opioid dependence by “a sufficient amount of drug to stabilize 
metabolic deficiency”, they introduced treatment by oral administration of methadone. 
Agonist medications such as methadone act through the same receptors as the addictive 
substance but have different rates of action. These agonists thus reduce the harmful 
behavior caused by addictive opioids all the while preventing withdrawal symptoms. It is 
essential to consider the effects of OMT in the presence alternatives such as drug free 
treatment, placebo medication or detoxification. A Cochrane review on methadone 
maintenance therapy  summarized that MMT was better able to retain patients in the 
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program compared to other alternatives and to suppress heroin use 52. It also stated that 
the patients were less likely to be involved in criminal activities. The usefulness of OMT 
or MMT is not just limited to stabilizing the metabolic deficiency and curbing illegal 
drug use. Preventing drug abuse is followed up by better control over their lifestyle, 
involvement in better social activities, decrease in criminal activities and promotion of 
good health. The services that are provided with OMT such as social services, counseling 
and medical services combined with the treatment is catered towards improving 
outcomes for the patients. 
Studies that evaluate the effects of OMT suggest that the treatment reduces illicit drug 
use, improves prenatal care thus leading to improved pregnancy outcomes 62. Although 
methadone has the ability to cause neo-natal abstinence syndrome, maintenance treatment 
provides steady drug concentration in blood preventing repeated withdrawal effects on 
the fetus 63. Buprenorphine has also been shown to be effective in pregnant women. 
Studies report lower placental transfer of buprenorphine as compared to methadone 
which reduces the exposure of fetus to the opioid, thus minimizing the chance of 
developing neonatal abstinence syndrome 8. A recently published Cochrane review article 
assessed the effectiveness of OMT with or without other ‘social interventions’ compared 
to no intervention in pregnant women in randomized controlled trials. They found four 
randomized controlled trials with a total of 271 subjects 53,64-66. The authors of the review 
presented a generalized conclusion stating that they did not observe significant difference 
between methadone, buprenorphine or slow release morphine to conclude if any of the 
treatment was superior 4. Their study indicated that methadone had a higher patient 
retention rate but buprenorphine lead to a lower neo-natal abstinence syndrome rate. 
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Implications of opioid abuse in pregnancy 
Apart from the harmful behavioral and physiological effects of opioids on the mother, 
there are many short and long term effects of opioids on the infants 67. Studies show that 
substance of abuse resemble naturally occurring neurotransmitters, thus their long term 
use precipitates neurobehavioral imbalance. A technical report titled “Prenatal Substance 
Abuse: Short and Long-Term Effects on Exposed Fetus” from the American Academy of 
Pediatrics concisely presents the effects of prenatal substance abuse 67. The study reports 
effects on birth-weight, withdrawal symptoms and neurobehavioral anomalies. The 
technical report illustrates that studies analyzing the long-term effects of illicit drug use 
on post-natal growth and development do not demonstrate specific effects. However, the 
combination of environmental factors along with lack of care mechanism and exposure to 
illicit substances have shown to negatively affect growth, behavior, executive functioning 
skills and predisposition to experiment with drugs. 
A retrospective cohort study analyzed the risk factors of preterm birth in opioid addicted 
pregnant women being treated with methadone between 2000 and 2006 68. The results 
demonstrated that overall preterm birth rate was 29% among methadone users. The rate 
of preterm birth in women who reported methadone use only was approximately 24%. 
Further analysis showed that abuse of other “supplements” (cocaine, alcohol, opiates or 
marijuana) alongside methadone increased the risk of preterm birth with rates up to 64% 
in pregnant women who used 3 or more “supplements” along with methadone. A study 
analyzing the effect of methadone treatment, tobacco use and social deprivation on fetal 
growth stated that the infants born of methadone using mothers had a significantly lower 
mean weight and smaller head circumference69. The cohort was 366 single births in a 
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Scottish population. The results after controlling for gestational age, tobacco use, 
maternal age, infant sex and parity showed that the infant born of methadone treated 
mother weighed 259 g less on average than infants born of healthy mothers 69. Another 
research that studied the relationship of maternal heroin and methadone use on infant 
birth weight stated that the reduction in birth weight associated with methadone was 279 
g on average, with a non-significant risk of low birth weight. Also, the use of heroin 
while using methadone counteracted the positive gain effects of methadone 11. There was 
an increase in NAS in newborns from 1.20 to 3.39 per 1000 hospital births per year 
between the years 2000 and 2009 70. The trend was congruent with the increase in opioid 
use in pregnant women from approximately 1.19 to 5.63% between the same time 
periods. The same study reported that infants with NAS had lower birth-weight as 
compared to controls (19.1% vs 7.0%) and had complications with their respiration 
(30.9% vs 8.9%). 
These studies show that pregnant women who are on OMT are at high risk of adverse 
pregnancy outcomes. There are several possible reasons that could have mediated those 
events along with the opioids. Lack of prenatal care, medical conditions, poor social 
support, and poverty could have contributed to poor pregnancy outcomes. It is also 
important to note that nutrition could have played significant role in those outcomes.  
Nutrition in pregnancy 
Energy intake: There is an increased requirement of energy in pregnancy due to the 
extra energy utilized by the fetus, uterus and the added increased activity of lungs and the 
heart 71-73. Several studies have measured the basal metabolic rate (BMR) and it was 
determined that there is an increase of 154 MJ on average throughout pregnancy 37. Also 
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studies have found that total energy expenditure increased by up to 16.5% during the 
third trimester of pregnancy. The estimates state that to gain an average of 12 kg during 
pregnancy, the extra amount of energy required would be 310 kcal/day 54. 
Protein: The estimate of total protein requirement during pregnancy is approximately 
925 g. It is based on the estimate that the women will gain 12.5 kg during that time and 
deliver a baby of 3.3kg 72. Other estimates suggest lower intake in the range of 497 to 696 
g over the pregnancy period. The recommendation by Food and Agriculture 
Organization/World Health Organization/United Nations University suggests that there 
should be an increase in intake of protein by 6 g per day during pregnancy 74.  
Vitamin A: There is an extra requirement of Vitamin A during pregnancy. The growth 
and development of the fetus and the maintenance of maternal tissues requires vitamin A 
37.Studies suggest higher requirements during third trimers of the pregnancy.  However, 
excess amount of retinol is considered teratogenic 75. 
Vitamin B1 (thiamin), B2 (riboflavin), B12 and folate: Thiamin and riboflavin 
(Vitamin B1 and B2) are essential for metabolic activities in cellular level in the body. 
Due to this reason there is a higher need of thiamin and riboflavin during the last 
trimester of pregnancy. Vitamin B deficiency has been shown to be associated with 
elevated levels of homocysteine 34. Elevated levels of homocysteine have been related 
with adverse pregnancy outcomes 35,36.  Folate supplementation during pregnancy is 
required to prevent megaloblastic anemia. Studies also show supplementation with folic 
acid to reduce the risk of neural tube defects 33. 
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Vitamin C: The growing fetus requires extra amount of vitamin C which it gains from 
maternal sources. It has an important role in improving the absorption of non-
hematological sources of iron 76. 
Vitamin D: For the absorption of calcium and its utilization, vitamin D is considered 
essential. It is needed for the development of skeletal structures of the fetus during the 
later stages of pregnancy. Studies have shown that deficiency in vitamin D is associated 
with lower bone mass in a child and poses a risk of osteoporosis in the future 47. However 
most of the vitamin D status in adult women is maintained through exposure to sunlight 
rather than diet, extra supplementation is not usually recommended unless the population 
is at a specific risk of vitamin D deficiency. 
Vitamin E: In pregnancy studies show that there is steady increase in the levels of 
plasma α-tocopherol and the results indicate that vitamin E plays vital role in platelet 
regulation and preventing aggregation of platelets thereby regulation placental blood 
circulation 77. The role of this micronutrient was also examined in pregnant women with 
preeclampsia. The study found that plasma concentrations of α-tocopherol and beta-
carotenes were highly reduced in patients with severe preeclampsia. However, 
supplementation with vitamin E did not reduce the risk of pre-eclampsia 78. 
Iron: There is an increased requirement of iron during pregnancy to meet the growing 
needs of fetus 79. The fetus absorbs most of the required iron during the third trimester of 
pregnancy. There is a risk of iron deficiency anemia in infants if it the baby is born 
prematurely 80. The Dietary Reference Value panel UK states that although there is 
higher utilization of iron during pregnancy, the requirements were met through increased 
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absorption, utilizing the stores in the mother and savings from stoppage of menstruation 
37. The subjects who are at risk of iron deficiency would need supplemental iron in their 
diet. Such groups include women from low socio-economic groups, teenagers and who 
have had successive births 37. 
Choline: Choline and its metabolites are primarily used in the physiologic purposes of 
signaling roles for cell membranes, cholinergic neurotransmission and in neurotransmitter 
synthesis pathways 81. There are many health effects of choline and studies have shown 
that its deficiency may play a role in liver and neurologic diseases 82. Choline is of 
greater interest because its deficiency has been seen in athletes, heavy drinkers and 
pregnant women82.  A study had shown that high dietary intake of choline around the 
time of conception was related to lower incidences of NTDs 50. Pre-clinical studies on 
mice have also shown that choline supplementation could minimize the health effects of 
prenatal alcohol exposure 83. It is highly likely that choline could play similar role in 
humans which makes the evaluation of this micronutrient necessary. 
Dietary Reference Intakes (DRIs): 
The Institute of Medicine of the National Academies provides nutrition recommendation 
intended for use by general public and health professionals. The DRI includes several 
different types of reference values of which Estimated Average Requirements is defined 
and listed 38-42. Estimated Average Requirements (EAR) is the average daily nutrient 
intake level estimated to meet the requirements of half of the healthy individuals in a 
group.
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Table 2: Estimated average requirements during pregnancy 
Age 
group 
(years) 
Vit A* 
(µg/day) 
Vit B1 
(mg/day) 
Vit B2 
(mg/day) 
Vit B6 
(mg/day) 
Vit B12 
(µg /day) 
Vit D 
(µg/day) 
Vit C 
(mg/day) 
Vit Eǂ 
(mg/day) 
Folateǁ 
(µg/day) 
Iron 
(mg/day) 
Choline 
(mg/day) 
Carboh
ydrate 
(g/day) 
Protein 
(g/kg/day) 
19-50 550 1.2 1.2 1.6 2.2 10 70 12 520 22 450 135 0.88 
 
* Measured as   micrograms (µg) of Retinol activity equivalents (RAE) per day 
ǂ Measured as milligrams (mg) of alpha tocopherol equivalents (a-TE) per day. 
ǁ Measured as micrograms (µg) of dietary folate equivalents (DFE) per day. 
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Nutrition in opioid dependent population 
A literature review was performed to identify the studies that evaluated the nutritional 
status of subjects undergoing OMT. The purpose of this review was to evaluate the 
studies that examined the nutritional behaviors of patients on OMT measured through 
specific nutrition survey or questionnaire We used search terms that included 
“buprenorphine maintenance OR methadone treatment or methadone maintenance OR 
methadone maintenance treatment OR opioid maintenance treatment, AND energy intake 
OR nutrient intake OR diet OR nutritional status or nutrition” to identify articles in 
PubMed. 
The inclusion criteria for the study were: a) study involving nutrition or dietary patterns 
in subjects undergoing OMT, b) study conducted in humans, and c) study published in 
English. The exclusion criteria were: a) studies that only had hematological analysis of 
subjects, b) studies that focused only on a specific serum protein or metabolite, c) studies 
that focused on generalized nutrition (e.g. “Determine your nutritional health” survey), d) 
literature review, and e) commentary or editorials. 
We initially found 127 articles using our search terms. There were 76 studies that 
remained after the exclusion of non-human studies. We reviewed the abstract of the 
remaining studies and examined them for relevance to our review. After examination we 
excluded 63 studies which were not relevant based on the contents of their study. After 
further examination we excluded studies that were not published in English, studies that 
only performed hematological analysis and studies that focused on generalized nutrition. 
We found a total of 4 studies which met our inclusion criteria. One of the studies 
examined the nutritional status of pregnant women on OMT. 
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Figure 2: Literature review on nutrition in subjects on opioid maintenance therapy 
  
Zador et al (1996) conducted a study on women (n=86) who were participants of a 
methadone clinic in Australia showed that they had lower daily energy intake (1547 kcal; 
95% CI: 1437-1657 Kcal) as compared to a standard acquired from National Dietary 
Survey on Adults in 1983(1920 kcal; 95% CI: 1851-1989 kcal) 57. The study also 
reported significantly lower intake of proteins (53g; 95% CI: 49-57g vs 80g; 95% CI: 76-
84g) and higher intake of carbohydrates from sugar (122g; 95% CI: 112-132g vs 101g; 
95% CI: 95-107g) in methadone users. The subjects also had significantly lower intake of 
magnesium, iron and zinc (based on percentage of recommended daily intake). 
Result of studies in PubMed 
using the search criteria (n=127)
Evaluation of human studies (n=76)
Studies further evaluated for their content 
(n=13)
Studies included in the 
review (n=4)
Studies excluded based on exclusion 
criteria (n=9)
Exclusion of studies irrelevant to 
our review (n=63)
Exclusion of non-human studies 
(n=51)
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Another study conducted in Poland in 2005 evaluated nutritional status of men (n=23) 
and women (n=7) who attended a methadone maintenance treatment clinic for four years 
58. Their dietary intake was examined before the start of the program and at the end of 4 
years into the program. Dietary intake was measured using 24 hour dietary recall. 
Compared to the recommended values in the study, the results showed at first test women 
had lower than safe levels of fibers, calcium, iron, magnesium, zinc, vitamin A and 
thiamin. Similarly in men, the intake levels of energy, fibers, magnesium, vitamin B1, 
B2, C, niacin, calcium and magnesium were lower than the recommended safe levels. 
The continuation of the same study reported that the participants’ diet primarily 
consisting of high calories and low nutrients had positive changes over the period of the 
course of methadone maintenance therapy.  
Similarly there was another study with fourteen participants (9 females and 5 males) who 
were in a methadone maintenance program along with 14 controls (10 females and 4 
males) whose diet was assessed by using a modified questionnaire developed by Peryam 
and Pilgrim 84. The basal metabolic index of the subjects in the methadone maintenance 
program was significantly higher than controls (28.85 ± 2.14 kg/m2 vs 22.84 ± 0.85 
kg/m2). Their analysis showed that the patients in methadone maintenance program 
reported a higher degree of affinity towards consumption of desserts, chocolates and 
candy. 
Tomedi et al(2012) conducted a study examining the nutritional status of pregnant 
women on OMT 59. The subjects were pregnant women on methadone maintenance 
therapy (n=22) in a hospital setting. Controls, also pregnant women (n=119) were 
recruited from another ongoing study. The nutritional status was measured using a semi-
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quantitative modified Block 98 food frequency questionnaire at 30 weeks of gestation. 
The study also examined nutritional biomarkers in blood.  
Study of the demographics of the study population revealed that the pregnant women 
who were on OMT were older (27.1 vs 31.3, p<0.01), unmarried (59.1% vs 26.9%, 
p<0.01), unemployed (81.8% vs 43.7%, p<0.01), smoker (72.7% vs 12.6%, p<0.01), and 
more depressed (based on Edinburgh postnatal depression scale, p<0.01) compared to 
controls. Mean pre-pregnancy basal metabolic index of pregnant women on OMT was 
lower (22.9 vs 26.4, p=0.02). After adjustment for confounders the nutritional analysis 
showed that the pregnant women on OMT had higher intake of energy (3033, 95% CI: 
2595-3571 kcal vs 2172, 95% CI: 2041-2303kcal). The biomarker analysis showed that 
after adjustment, homocysteine levels were lower and carotenoids levels were 
significantly lower in the methadone exposed group. Another important observation in 
this study was that levels of daily folate intake were lower than recommended levels in 
both exposed and the control groups. Elevated levels of serum homocysteine could mean 
that the pregnant women in OMT have thiamin, riboflavin, folate or vitamin B12 
deficiencies34. Equally important fact is that elevated homocysteine level is associated 
with adverse pregnancy outcomes 35,36 which makes the finding of this study concerning. 
Summary of the review on nutrition in opioid dependent population 
The studies regarding nutrition in opioid dependent population showed mixed results 
regarding energy intake and basal metabolic index. However, they shared a common 
theme. Most of their energy was derived primarily from carbohydrates consisting of non-
complex sugars and their diet had lower amount of micronutrients as compared to 
controls or lower according to recommended daily intake requirements. These 
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observation shows that there are inadequacies in diet of patients on OMT. Since the 
energy and micronutrient requirements of pregnant population are considered to be 
greater than the general population it can be implied that pregnant women on OMT could 
have poor nutrition status which can put them at a risk of adverse pregnancy outcomes. 
The study conducted by Tomedi et al (2012) was a pilot study and the small sample size 
could have resulted in non-significant results in the intake of micronutrients after 
adjustment. Hence, further studies are required in this population to confirm the poor 
nutritional status of pregnant women. Also, the effect of nutrition status on pregnancy has 
not been evaluated specifically on pregnant women on OMT. Our study has greater 
relevance in the light of lack of information regarding the nutritional deficiencies in 
pregnant women on OMT. The results of this study can be used to plan interventions to 
promote proper nutrition in pregnant women on OMT leading to improved pregnancy 
outcomes.  
Measurement of nutrition 
Methods to estimate dietary intake can be divided into two broad categories: 1) the 
measurement of actual concentration of nutritional biomarkers in biological specimen 
along with anthropometric measurements, 2) the measurement of what the people are 
eating. These two approaches appear distant to each other but share the common outcome 
of measuring the nutritional status of a person. The first method focuses primarily on the 
final output, which is the end product of nutrition after the food is metabolized, absorbed 
and then distributed into the body producing the result in terms of plasma level 
concentrations, hematocrit levels, weight gain, muscle mass and fat mass. The second 
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method focuses on what the subject is consuming, how much of each food group is 
contained in his her diet.  
There are various advantages and disadvantages of the two methods. The first method 
where plasma micronutrient levels and hematocrit level are measured are better suited to 
describe the nutrition at the period surrounding examination. It would be difficult to 
predict the overall dietary patterns or what the subjects are eating based just on the 
plasma levels of the micronutrients. Also the cost of conducting such analysis would be 
significantly greater. The second method focuses directly on what the patients are eating. 
Several self-reported methods are available to estimate patients’ dietary intake, including 
the24 hour recall, food records and food frequency questionnaire (FFQ), each with its 
own advantages and limitations 85-87. The final output of these self-reported measures are 
what the person is eating in general. These methods provide excellent information, 
depending upon the instrument used, on what the person eats in his day to day life. This 
allows the researchers to evaluate if that diet has any role in the outcome that they are 
evaluating. However, these methods fail to take into account if there are any problems 
with the absorption of the food or if the food is not being metabolized properly. Recall 
biases could also affect the result of such analysis. The primary goal of this research 
involves the measurement of dietary intake in pregnant women. Our prime goal is to 
evaluate if there are any differences in nutritional intake in pregnant women on OMT 
versus the controls. The observance of any disparity can help us identify those deficiency 
and formulate intervention. In the following sections Block brief food frequency 
questionnaire has been described which was used to collect nutritional information from 
the pregnant mothers in our study. 
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Block Brief Food Frequency Questionnaire 
The interest of this research in the nutrition of pregnant women revolves around their 
usual diet. As discussed previously, adequate nutrition is a vital part in prenatal health 
care. There is rich information on the effects on inadequate or excess energy intake and 
effects of micronutrient supplementation on pregnancy outcomes and its long term 
effects. Nutritional analysis of pregnant women can provide clear information on their 
dietary intake and allow us to develop interventions if significant deficiencies that may be 
harmful for the growth of the fetus are observed. 
The accuracy in measurement of nutrient intake and the context of the research are 
important factors in determining the technique to be used for evaluation of nutritional 
status. Various methods have been developed to measure dietary intake. The 24 hour 
recall method is a simple method, which can be administered by interviewer with 
minimal training. It asks the respondents to recall intake in the last 24 hours. However, 
there is significant deviation in day to day intake of food which can lead to imprecise 
estimates of nutrient intake in individuals 85,86. The history method uses food model and 
consists of an extensive interview to study an individual’s diet 87. Diary method applies 
the concept of using a diary for a specific period of time to record food intake. Method 
such as seven day record has been used in studies. It is a type of diary method and it is 
oriented towards minimizing errors of recall. The analysis of nutritional biomarkers is a 
precise way of establishing the nutrients present in an individual’s body. It can provide a 
very accurate measurement of the nutritional status of an individual. The drawbacks are 
the expenses and methodological difficulties regarding collection and analysis of blood 
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sample. Also such biomarkers are specific to a certain period of time and do not account 
for the fluctuation of such biomarkers in blood.   
FFQ is used to measure usual and customary intake of food. The results are obtained by 
recording the frequency and portion size of a list of food items. Various FFQ have 
different food lists and work on different time frames of recall. This versatility allows the 
FFQ to control for variation in food intake due to seasonal variations. The FFQ used in 
our study was the Block Brief 2000 FFQ (NutritionQuest©). It consists of 72 food items. 
The average administration time is around 15-20 minutes. Due to the reduced list of food 
items, this FFQ could underestimate the estimates of energy and macronutrient intake. It 
is possible however to rank individuals along the distribution of their intake thus 
cancelling out the effect of underestimated intake estimates. 
Validity and use of Block Brief 2000 FFQ 
Development of the Block Brief 2000 FFQ was based on the same method as the full 
Block 98 FFQ. However, the data set used for the development of Block brief 2000 was 
NHANES III while Block 98 FFQ had used NHANES II. The list of food items were 
separate for White, Hispanics and African American so that food items specific to a 
single group was not omitted. Another change was the method of asking portion sizes for 
non-unitary foods using portion size photos to aid the estimation. Block 98 FFQ has been 
widely used and has been validated by several studies 88,89.  
The validation of the Block Brief 2000 FFQ has not be specifically performed. However, 
a study was performed which evaluated a reduced questionnaire (food items =60) which 
was based on Block 98 questionnaire 90. The study evaluated Block98 and reduced 
questionnaire against a “three four-day dietary intake” records in the Women’s Health 
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Trial pilot. The study reported that in the usual diet group the correlation between 
Block98 and multiple dietary records was 0.57, and the correlated between reduced 
questionnaire and multiple dietary records was 0.56. Similarly, in the reduced fat intake 
group, the correlation between Block98 and dietary records was 0.62, and that between 
reduced questionnaire and dietary records was 0.65. The result suggested that the reduced 
questionnaire would essentially be as effective as Block98 in measuring the dietary 
intake. The Block Brief 2000 is a reduced version of Block98, however, compared to the 
reduced questionnaire, it contains additional food items. Thus, the construction of Block 
Brief 2000 as an intermediate between the Block98 and reduced questionnaire from the 
Block et al study suggests similar validity. Block Brief 2000 has been in use in 
contemporary research and is an effective instrument in estimating dietary intake 91-93 
Factors that affect diet and nutrition: An ecological model 
There are a multitude of factors that affect food preferences, dietary patterns and 
nutritional status of an individual. There are individual factors such as personal 
preference, taste, affordability followed up by the social and familial effect on diet such 
as effect on ethnicity, race, and social-perception on food choice. On a macro level, food 
pricing, advertisement, and government food programs could affect food choices. An 
ecological model representing the factors that could explain food choices which 
ultimately affects nutritional status is represented in figure 3. 
The first level that immediately affects nutrition as shown in the ecological model is food 
choice. Taste is an important factor that drives our nutritional behavior94,95. Our basic 
sensations of taste which is affected primarily by our genetics and physiology is 
modifiable by other external factors such as age, race, culture, and location96,97 . Another 
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factor that could affect food consumption is the time required to prepare food and access. 
The amount of work and conditions surrounding it affects meal choices as long commute 
from home, evening shifts and associated time challenge is related with purchasing 
takeout meals 98.  
On the second level the interpersonal factors that consist our immediate surrounding are 
responsible in determining what food we eat. Four environmental factors have been 
identified by a study by Wansink that affect the amount of food eaten. It includes the 
surrounding (pleasantness); access and convenience; company (friends or family who 
encourage eating); and distractions such as television which can cause a person to lose 
track of how much he/she is eating 99.  
Finally on the third and fourth levels are the factors that are distant towards actual food 
choices but affect the purchase and consumption of food on a bigger levels. These levels, 
the community level and the policy level have an overarching effect over overall food 
choices in social or national context. Other factors such as marketing of food (functional 
organic foods), awareness of nutrient content of food groups, cost of food, social 
perception of a product safety and prices affect how much a food is consumed 100-102. 
There are larger effects of socio-cultural norms on dietary patterns 103 along with 
perceptions, attitudes and beliefs about nutrition 95. Although the trends are changing due 
to social change, media and availability of information, it is important to consider how 
perceptions affect choices of food 95. 
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Figure 3: Ecological model: Factors that affect food choice and nutritional status in 
individuals 
  
Policy: Governemnt support 
programs, advertisements
Community: Access to food, social 
norms, pricing, religious beliefs
Interpersonal: associaiton with family, 
friends, work environment, perceptions 
about nutrition and healthy diet
Individual:  age, socio-economic status, 
ethnicity, disease condition and genetics, 
dietary preference, attitude and beliefs on 
nutrition
Food Choice: Nutritional status 
in individuals
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CHAPTER THREE: METHODS 
Data source 
The data for our study was derived from an ongoing study in University of New Mexico 
Health Sciences Centre. The “Ethanol Neurodevelopment Infant and Child Health” 
(ENRICH) study, aims to refine analytical procedures to detect the effects of prenatal 
alcohol exposure earlier in a child’s development. The procedures consists of several 
questionnaires and a battery of biomarkers test to ascertain alcohol, tobacco and 
substance exposure. Magnetoencephalography (MEG) and electroencephalography 
(EEG) are used to analyze neurophysiological indices to detect indicators of fetal alcohol 
exposure. Such early detection could pave a way to earlier health and behavioral 
intervention in exposed population thereby decreasing the chances of development of 
disabilities in children with fetal alcohol spectrum disorders. This work has been 
supported by the R01 AA021771 research grant from NIAAA/NIH. 
ENRICH is a prospective cohort study. It follows a cohort of pregnant women recruited 
during their prenatal visits, and their newborn over a course of 20 months after delivery. 
The patients are recruited from University of New Mexico Milagro clinic and UNM 
General Obstetrics clinic. There are two major study groups in the ENRICH study. First 
group are the healthy controls: pregnant women who have no exposure to OMT or have 
ever used illicit drugs in their lifetime. They are also required to have minimal exposure 
to alcohol or tobacco.  The second group consists of pregnant women who are on OMT. 
The subjects in this group have other exposures such as alcohol, tobacco and other 
substances. The inclusion criteria for the parent study were: 1) age ≥ 18 years; 2) 
Singleton pregnancy which was confirmed by an ultrasound; 3) residence in Albuquerque 
metropolitan area (plan to stay here for the duration of study, approximately 2 years); 4) 
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capable of providing written consent; 5) No use of cocaine, crack-cocaine, ecstasy or 
methamphetamine for exposed groups; lifelong abstainer of illicit drugs for controls 6) no 
major structural anomalies identified prenatally 
Assessments at baseline (Study visit 1) 
At baseline (V1), demographic information such as age, marital status, ethnicity 
(Hispanic or not), race, education level, employment status, health insurance status, 
country of birth and primary language use in home was recorded. Medical and 
reproductive health information such as self-reported pre-pregnancy weight and height, 
diagnosed medical conditions, information on their last menstrual period, current 
gestational age, gravidity, parity, complications in current pregnancy and information on 
any dietary supplements the subjects are taking was collected. Maternal alcohol 
consumption is also measured based on time line follow back calendar104(TLFB) around 
LMP and at visit 1, along with Alcohol Use Disorders Identification Test (AUDIT)105 and 
TWEAK scores106. Lastly information on tobacco and substance use was recorded. 
Biological specimens (serum, whole blood, urine) were also collected at the first 
interview. They were used to ascertain alcohol, tobacco and substance use. The alcohol 
biomarkers that were examined were serum gamma-glutamyl transpeptidase (GGT), 
disialo carbohydrate deficient transferrin (%dCDT), and phosphatidylethanol (PEth) in 
the mother’s whole blood. The study used the following cut-offs to classify the subjects 
as positive to alcohol exposure: GGT>40 U/L107, %dCDT>2.0108-110 and PEth ≥ 
8ng/ml111,112.  
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Assessments during the hospital stay after delivery (Study visit 2) 
The second interview (V2) was conducted during the patient’s stay in the hospital for 
delivery. In the second interview, information regarding use of supplemental vitamins, 
tobacco, alcohol and substance use was recorded. Information on the subject’s perceived 
stress was also included. In the second interview, an interviewer administered a food 
frequency questionnaire (FFQ) which was used to evaluate the dietary intake of the 
participants in the study. The study used Block 2000-Brief FFQ to estimate the daily 
intake of nutrients in the participants. Biological specimens were also collected to 
ascertain if the subject had used alcohol or other substances. The alcohol biomarkers 
examined at the second interview were: GGT, %dCDT, PEth in maternal blood and PEth 
in infant dry blood spot (DBS). The cutoffs used for GGT, %dCDT and PEth in maternal 
blood were as described earlier. A cut off value of DBS-PETH >20ng/mL113 ,urine ethyl 
glucoronate (uEtG) ≥ 25 ng/mL and urine ethyl sulphate (uEtS) ≥ 7 ng/mL111 was used to 
classify the subjects as positive to alcohol exposure. 
Selection of participants for the nutritional analysis from the parent cohort: 
All of the participants in the nutritional assessment study were selected from the 
ENRICH parent study. The following inclusion criteria were applied: 1) Completion of 
both visit 1 and visit 2 interviews; 2) completion of the Block Brief 2000 FFQ at visit 2. 
The following exclusion criteria were applied: 
For exclusion of heavy to moderate alcohol users we excluded the subjects who 
1) Were positive for any two alcohol biomarkers (analyzed at visit1 or visit2) 
or 
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2) Had consumed more than 1.5 units of absolute alcohol per day on average around 
their last menstrual period calculated using timeline follow back calendar 
For exclusion of unrealistic energy intake values for pregnant women, subjects who were 
outliers with respect to energy intake (<1,000 Kcal/day or > 6,000 Kcal per day) were 
excluded.  
At the time of analysis, 61 subjects in the ENRICH parent study had completed the visit 2 
interview and had completed the food frequency questionnaire. After we applied the 
exclusion criteria, 7 subjects were excluded; 4 subjects were excluded because they were 
either positive for 2 or more alcohol biomarkers or had intake of over 1.5 units of 
absolute alcohol per day and 3 subjects were excluded because their energy intake was 
either above 6000 Kcal per day or lower than 1000 Kcal per day. In total 54 subjects were 
qualified for the nutritional analysis.  
The subjects undergoing OMT as identified by their recruitment from Milagro clinic 
which offers treatment to pregnant women with substance use disorders were classified as 
OMT group. Their exposure to OMT was further confirmed by their self-report and 
medical records. Alcohol, tobacco and substance use in these population was also 
confirmed using self-report and analysis of biological specimens. The healthy controls 
were those subjects who had no exposure to OMT. They also did not have any or 
minimal exposure to alcohol identified by self-report and confirmed by analysis of their 
biological specimens for alcohol biomarkers. In total 34 subjects were qualified to be 
included in the OMT group and 20 into the healthy control group for final analysis. 
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Figure 4: Study participant selection for nutritional analysis 
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Block Brief Food Frequency Questionnaire 
The Block Brief Food Frequency Questionnaire was used to evaluate the nutritional 
status in pregnant women during their hospital stay after their delivery. The FFQ was 
administered by the researchers interviewing the patients for V2. As mentioned 
previously in the literature review section, the FFQ measures usual and customary intake 
in the study participants. Information on different types of food groups, their frequency of 
consumption and the portion size are all collected during the interview using the FFQ 
instrument. The information thus collected goes through analysis at NutritionQuest© and 
results which are in the terms of energy, micro and macronutrients consumed per day are 
generated. This information was collected as a part of our study and was used in the 
nutritional analysis. 
 Apart from the measurement of food, the FFQ also collects information on intake of 
alcohol and vitamins. The consumption of alcohol related beverage plays a significant 
role in the nutritional analysis. A review by Yeomans et al, 2010 effectively summarizes 
the effect of alcohol consumption on its effect on appetite and the balance in energy 
intake114. The study summarizes that short term alcohol intake could possibly promote 
food intake and that alcohol consumption is additive to energy obtained from other 
sources. Although the study suggest that mild to moderate alcohol intake might not be 
associated with weight gain, nonetheless there are effects on appetite with the 
consumption of alcohol. The food frequency questionnaire lists 3 items in the beverage 
section: 1) beer, 2) wine or wine coolers 3) liquor or mixed drinks along with the 
frequency of intake in the past year and portion sizes to measure alcohol intake. 
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Description of covariates 
Inclusion of the covariates was based on the ecological model on nutrition. As described 
earlier, individual preferences, economic status, societal and cultural norms, attitudes and 
beliefs on diet along with governmental policies could have effect on dietary habits. 
Under the restraints of the study design, the following covariates will be used to adjust 
for the differences in nutritional intake in our study. 
Age: Age was measured at the first interview and is expressed as years. 
Marital Status: Marital status was ascertained in the first interview. Marital status was 
categorized as 1) single, never married; 2) married, living with spouse; 3) not married, 
living with partner; 4) separated from spouse; 5) divorced; 6) widowed. In our analysis 
used a binary variable for marital status 1=married or not married, living with partner and 
0=single, not married or separated or divorced. 
Ethnicity: The question regarding ethnicity which recorded if the subject was Hispanic, 
Latino or of Spanish descent was asked in first interview. A binary variably (1=yes, 0= 
no) was used to record the answer. 
Race: The information on race was recorded during the first interview. Race was 
categorized as: 1) White; 2) Black or African-American; 3) American Indian or Alaskan 
Native; 4) Asian or Asian American or Pacific Islander; 5) Other group; 6) prefer not to 
answer. For our calculation a binary variable for race was used (1= White. 0=others). 
Education: Education level was recorded during the first interview. It was categorized as: 
1) less than high school graduate; 2) high school graduate or GED; 3) some college or 
vocational school; 4) college degree; 5) Masters, Doctorate or professional degree. A 
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binary variable for education for the calculations was used. Education level was 
dichotomized as high school education or lower and some college education or higher. 
Employment status: Employment status was recorded as a binary variable at the first 
interview. 
Insurance status: Insurance status was used as a binary variable in our analysis. First 
group was subjects who had Medicare as their insurance and the other group had any 
other insurance except Medicare. 
Presence of any medical condition: During the first interview the subjects were asked if 
they had any medical condition that required treatment. Information on any medical 
conditions described was recorded. This information was first self-reported and then 
confirmed using electronic medical records. 
Parity: Parity is the number of pregnancies carried to viable gestational age and delivery. 
It was measured during the first interview. 
Gravidity: Gravidity refers to the number of times the women has been pregnant. It was 
also recorded at the first interview. 
Tobacco use: Tobacco use was recorded during the first interview. The information 
recorded was current smoking, if yes then the amount of cigarette smoked daily. If the 
subject was not a current smoker and if the subject was a user previously, then the 
amount that the subject used to smoke prior to quitting was acquired. For our analysis, 
the smoking status of the subject at visit 1 and overall smoking status (i.e. did the patient 
ever smoke more than 100 cigarettes in lifetime) was used. 
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Substance use: Other illicit substance and their frequency of use during pregnancy was 
recorded during the first interview and at the second interview. The study collected the 
information on substances such as marijuana, cocaine, methamphetamine, 
benzodiazepines, barbiturates, opioid analgesics, methadone and buprenorphine. Self-
reported frequency of use was collected from the subjects. Toxicology screens for 
substances were conducted to confirm the self-report.  
Data analysis plan 
The description of the baseline demographics of the study population (measure at first 
interview) was described using means (for continuous variables) and percentages 
(categorical variables). The difference in the general characteristics of the groups was 
evaluated using students t-test for the continuous variables and the fisher exact tests for 
categorical variables.  
For specific aim I, to determine the difference in energy intake in pregnant women on 
OMT compared to non-opioid using pregnant women, we performed a student’s t-test. 
The dependent variable was total energy intake measured in kilo-calories per day. The 
independent variable was OMT status. We also performed the same test on log 
transformed energy intake. This method was used to account for the non-normal 
distribution of energy intake. We also examined the effect of other demographics factors 
such as race, ethnicity, marital status, employment, education level and health insurance 
type on energy-adjusted macronutrient intake115. However, to minimize the effect of 
multiple testing we used multivariate analysis of variance (MANOVA) instead of 
individual tests on the dependent variables. MANOVA allows us to perform a joint test 
for any significant effect among a set of variables at a fixed alpha level. The dependent 
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variables were energy-adjusted carbohydrate, protein and total fat intake. Another 
analysis was a multivariate analysis of covariance (MANCOVA) model that took into 
account the age, pre-pregnancy BMI, ethnicity, education level, marital status, 
employment status of subjects along with the variable OMT status. Inclusion of variables 
in the MANCOVA model was ascertained by the MANOVA analysis. Independent 
variables with a significance level of p<0.2 were selected into the MANCOVA analysis. 
The rationale for this analysis was to control for the confounders that could have affected 
energy-adjusted macronutrient intake. This was followed up by a multivariate regression 
for each individual energy-adjusted macronutrient. We also calculated the percentage of 
energy coming from different sources such as carbohydrates, fats and proteins. This 
analysis evaluated the primary macronutrient groups that formed the sources of energy in 
OMT and non-opioid using pregnant women.  
For specific aim II, to determine the difference in intake of vitamins A, B1, B2, B6, B12, 
C, D, E, and beta-carotenes in pregnant women on OMT compared to controls, we 
performed a student’s t-test on unadjusted micronutrient intake. In the next step, the 
dependent variables (vitamins and carotenoids) were adjusted on the basis of total caloric 
intake. The initial adjustment by total calorie intake takes into account the ratio of 
micronutrients to energy 115. To account for multiple testing, multiple analysis of variance 
on the micronutrients as a group was performed. The dependent variables were energy-
adjusted vitamin A, thiamin, riboflavin, vitamin B6, vitamin B12, vitamin C, vitamin D, 
vitamin E, folate, iron and choline. To adjust for other confounders MANOVA test was 
performed by individual dependent variables such as race, ethnicity, education level, 
marital status, employment status and type of health insurance. Finally a multiple analysis 
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of covariance was performed to control for age, pre-pregnancy weight, ethnicity, race, 
education level, marital status and employment status. Inclusion of a covariate in the 
MANCOVA was dependent upon the significance of the MANOVA test. Independent 
variables with p<0.02 were included in the final model. It was followed by a multivariate 
regression for those micronutrients that were observed to have significant difference in 
the energy-adjusted analysis.  
For specific aim III, to determine the difference in intake of folates and iron, we 
performed student’s t test. Then, the dependent variables were adjusted on the basis of 
total caloric intake. We performed the t-test to calculate the difference in intake after 
adjustments. The two variables (folate and iron) were included in the MANOVA model 
along with all other micronutrients to evaluate the composite effect of OMT exposure and 
other covariates. A multiple analysis of covariance was performed to control for age, pre-
pregnancy weight, ethnicity, race, education level, marital status and employment status 
based. Inclusion in the MANCOVA was dependent upon the significance of the 
MANOVA test. Independent variables with p<0.02 were included in the final model.  
Finally, a multivariate regression was performed to control for age, pre-pregnancy 
weight, ethnicity, race, education level, marital status and employment status.  
For specific aim IV, to assess if the study participants meet the EAR based on their 
exposure, we calculated the proportion of subjects who met the EAR for the macro and 
micronutrients through their diet alone. Secondly, we calculated the proportion of study 
subjects in each group who met the EAR after addition of micronutrient supplements.  
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For data analysis, we modified the covariates into simpler groups to account for the small 
sample size in our study. Marital status was converted to a binary variable married/not 
married but living with spouse and single/separated/divorced/widowed. Race was 
converted into a binary variable White and others. Education was converted into a binary 
variable high-school or lower and some college or higher. All analyses were conducted 
using Stata (version 13, Stata Corp, College Station, Texas, USA). 
Multivariate analysis of variance (MANOVA) 
MANOVA is generalized analysis of variance (ANOVA) when there are two or more 
dependent variables. It is a statistical test that compares the multivariate means of several 
groups116. When there are several dependent variables and we try to ascertain the effect 
of an independent variable, multiple testing might lead to a type I error due to inflation of 
α. To control for the type I error, MANOVA allows us to perform a joint test for any 
significant effect among a set of variables at a fixed alpha level. After a significant effect 
of an independent variable is found among a set of variables, ANOVA or regression 
analysis can be performed to ascertain the effect on individual variables. Thus, we can 
state that MANOVA generally describes a pattern of difference in means in a group of 
dependent variable which is due to an independent variable. A MANOVA test generally 
is dependent upon a set of conditions that determine if the distribution of data with 
respect to each other are normal and correlated. We analyzed the correlation between the 
dependent variables to assess the effectiveness of MANOVA for our analysis. The 
inclusion of multiple variables included in our study would make it difficult to prove 
multivariate normality, hence multivariate normality of the dependent variables was not 
be tested. Similarly, multivariate analysis of covariance (MANCOVA) is an extension of 
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analysis of covariance (ANCOVA) where there are multiple dependent variables and 
continuous independent variables need to be controlled. 
Power calculations 
We based the sample size calculation on specific aim I, to determine the differences in 
energy intake in pregnant women on OMT and non-opioid using pregnant women. In that 
analysis the dependent variable was total energy intake and independent variable was 
OMT status. We used sample size calculating software (PASS 13, Kaysville, Utah) for 
the power analysis. 
The alpha value which is the probability of rejecting the null hypothesis when the null is 
true was set at 0.05. We performed the power analysis to calculate the sample size 
required in OMT exposed and the control group to achieve power in the range of 0.8 to 
0.9. The sample size for group 1 (OMT group) was varied from 10 to 50 at increments of 
10 and power for each combinations were calculated. 
We used the estimates for difference in energy intake from a previous study 59.The mean 
energy intake in each group along with standard deviations was extracted for the 
calculations. We used these estimates to calculate the sample size in each group. We also 
performed power calculations based on the estimates of Vitamin A and Iron intake from 
the same study. The power calculation was performed to account for the different 
analysis we were performing on the data and the difference in energy intake versus intake 
of micronutrients in a person’s diet. The basis of multiple power analysis was based on 
the hypothesis that caloric intake would not directly correlate with micronutrient intake in 
our study population. Another driving factor was the difference in the levels of 
micronutrient intake in the previous study 59. They had observed that the difference in 
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average energy intake was significantly greater but the difference in micronutrient 
although present was non-significant. Hence, use of the same power analysis and sample 
size calculation could possibly lead to our study to have less power in detecting a 
difference in micronutrient intake. The result from the preliminary power analysis is 
shown in table 3, 4 and 5. 
We used the estimates of variance in energy and micronutrient intake from a previous 
study and used projected sample size for our study to calculate minimum detectable 
difference for our study. The results are shown in table 6. 
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Table 3: Power calculation based on the estimates of energy intake (specific aim I) 
Target 
power 
Actual 
power 
N1 N2 N μ1 μ2 μ1 - 
μ2 
σ1 σ2 Alpha 
0.8 1.0 10 2 12 3033.0 2172.0 861.0 223.8 66.8 0.05 
0.9 1.0 10 2 12 3033.0 2172.0 861.0 223.8 66.8 0.05 
 
Table 4: Result of power calculation based on the estimates of Vitamin A intake (specific 
aim II) 
Target 
Power 
Actual 
Power 
N1 N2 N μ1 μ2 μ1 - 
μ2 
σ1 σ2 Alpha 
0.80 0.88510 20 4 24 3326.0 3818.0 -492.0 498.0 183.7 0.050 
0.90 0.92061 20 5 25 3326.0 3818.0 -492.0 498.0 183.7 0.050 
 
Table 5: Power calculation based on the estimates of Iron intake (specific aim III) 
Target 
Power 
Actual 
Power 
N1 N2 N μ1 μ2 μ1 - 
μ2 
σ1 σ2 Alpha 
0.80 0.80259 50 94 144 6.8 7.3 -0.5 0.6 1.5 0.050 
0.90 0.90072 50 136 186 6.8 7.3 -0.5 0.6 1.5 0.050 
Target Power was varied between 0.8 and 0.9.. 
Actual power was the power obtained according to the estimated differences and sample 
size. 
N1( exposed group) and N2 (controls) are the number of items sampled from each 
population. 
N is the total sample size (N1 + N2) 
μ1 and μ2 are the estimated mean (values from previous studies were used) 
μ1 - μ2 is the difference between the estimates of the means 
σ1 and σ2 are the estimated standard deviation for exposed and controls respectively. 
Alpha, the probability of rejecting the null hypothesis when it is true was set at 0.05. 
The means and standard deviations for the power calculation were derived a previous 
pilot study59. 
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Table 6: Calculation of minimum detectable difference based on estimated of sample size 
Actual 
power 
N1 N2 N μ1 μ2 μ1 - μ2 σ1 σ2 Alpha 
Based on estimated of caloric intake (Specific Aim I) 
0.573 40 25 65 2200 2100 100 180 180 0.05 
0.89 40 25 65 2250 2100 150 180 180 0.05 
0.99 40 25 65 2350 2100 200 180 180 0.05 
Based on estimates of Vitamin A intake (Specific Aim II) 
0.48 40 25 65 3600 3800 -200 400 400 0.05 
0.82 40 25 65 3500 3800 -300 400 400 0.05 
0.97 40 25 65 3400 3800 -400 400 400 0.05 
Based on estimates of Iron intake (Specific Aim III) 
0.56 40 25 65 6.3 7.3 -0.6 1 1 0.05 
0.87 40 25 65 6.5 7.3 -0.8 1 1 0.05 
0.98 40 25 65 6.8 7.3 -1.1 1 1 0.05 
Actual power was the power obtained according to the estimated differences and sample 
size. 
N1( exposed group) and N2 (controls) are the number of items sampled from each 
population. 
N is the total sample size (N1 + N2) 
μ1 and μ2 are the estimated mean (values from previous studies were used) 
μ1 - μ2 is the difference between the estimates of the means 
σ1 and σ2 are the estimated standard deviation for exposed and controls respectively. 
The means and standard deviations for the power calculation were derived a previous 
pilot study 59. 
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Summary of power calculations 
The results from the power analysis showed that very small sample size in each group 
were enough to achieve a significant power (100%) to detect the estimated difference in 
energy intake between the groups. This was attributed to the significant difference in the 
energy intake in between OMT and the control group in the previous study. Similarly the 
power calculation based on the estimates of Vitamin A intake showed that 90% power 
could be achieved with a sample size of 24 (20 in OMT group and 4 in controls) to detect 
an estimated mean difference of 492 IU/day. The third power calculation showed that it 
would be difficult to detect a significant difference in daily intake of iron between the 
groups. To have a 70% power to detect an estimated difference of 0.5 g/day in iron 
intake, the sample size needed would be 121 (50 in the OMT group and 71 in the control 
group).  
Based on the estimates of our target sample size (n=40 in the exposed group and n=25 in 
controls) we can observe a difference of 150 Kcal in energy intake with 90% power, a 
difference of 300 IU in vitamin A intake with 82% power, and a difference of 0.8 mg in 
iron intake between the groups with 82% power. 
Human research review committee (HRRC) approval 
The data has been abstracted from an ongoing NIH funded study which has HRRC 
approval. The Principal Investigator of the study has agreed to provide all the data 
required for the study. Available data is de-identified; hence this study did not require a 
further HRRC approval. 
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CHAPTER FOUR: RESULTS 
 
This chapter presents the results of our analysis pertaining to the aims of the study. 
Description of the study population is presented first, which is followed up by the 
analysis of difference in energy and nutrient intake. The analysis is presented as 
unadjusted analysis based on exposure status followed up by unadjusted analysis based 
on covariates and finally adjusted analysis (multivariate linear regression). 
Description of the study population 
At the time of analysis the ENRICH study had 61 participants who had completed Visit 2 
along with complete information on nutritional analysis. Fifty four subjects out of the 61 
who had complete information qualified for our study. The demographic characteristics 
of the study population are presented in Table 7. The mean age of the study population 
was 27.0 ± 5.2 years. Majority of the study participants were under the age of 30. Of the 
total study population, 64.8% were Hispanics. Ninety percent of the population identified 
themselves racially as White. The marital status of the participants varied with 44.4% 
married or living with partner and 55.6% either single, separated or divorced.  
Approximately 61% of the study population had education level of high-school or lower, 
and 38.9% had some education after high-school. The employment rate of the study 
sample was low at approximately 31%. Approximately 79% of the study sample had 
Medicaid as their health insurance. 
The physical health, reproductive characteristics, alcohol, and tobacco use the study 
sample has been described in Table 8. The average pre-pregnancy weight of the study 
participants was 148.5 ± 32.3 lbs. The BMI on average was 26.0 ± 5.9. At baseline 60% 
of the subjects had a BMI of 24.9 or lower. Approximately 20% of the subjects had a 
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BMI in between 25.0 and 25.9. About 19% of the subjects had a BMI of 30 or above. At 
the time of recruitment (V1) their mean gestational age was 23.2 weeks. On average the 
study participants had around 3 pregnancies. However, for 27% of the participants it was 
their first pregnancy. A significant proportion of the study subjects (63%) reported that 
the pregnancy was unplanned. Approximately 50% of the participants revealed that they 
had some kind of medical condition that required treatment.  Most prevalent conditions 
were hepatitis (25.9%), anxiety (16.7%) and depression (16.7%).  
Population characteristics based on exposure to Opioid Maintenance Therapy 
Table 7 and 8 shows the population characteristics based on exposure to OMT. There was 
no significant difference in the average age in the two groups (p=0.16), however, the 
subjects in the control group were slightly younger (25.7 years in controls vs 27.8 years 
in OMT exposed). Seventy percent of the subjects in the OMT group identified 
themselves as Hispanics compared to 55% in the control group (p=0.37). There was a 
significant difference in the marital status in the subjects in OMT versus control group 
(p=0.02). Higher proportion of the subjects in the OMT exposed group were 
single/separated/divorced (67%) but a larger proportion of the subjects in the controls 
were married or cohabitating (65%). There was a significant difference in education level 
between OMT exposed and controls (p=0.02). In the OMT exposed group 73.5% of 
subjects had an education status of high-school or lower compared to 40% in the controls. 
Controls had a higher proportion of subjects who had some college degree or higher 
compared to the OMT exposed group (60% vs 26.5%). Employment rate was 45% in the 
control group but 23.5% in the OMT group. In the OMT exposed group 91.2% of the 
subjects had Medicaid compared to 60.0% in the control group (p=0.01). 
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There was no significant difference in pre-pregnancy weight (p=0.95), BMI (p=0.85) or 
gestational age at first interview (p=0.10) in between the two study groups. However, 
45% of the subjects in control group reported that they did not plan to get pregnant with 
the baby compared to 73.5% in the OMT group (p=0.04). On average subjects in the 
OMT group had been pregnant 3.4 times compared to 1.9 times in the control group 
(p<0.01). We observed a significant difference in presence of a medical condition in 
subjects between the two groups (p=0.01). Sixty four percent of the subjects in the OMT 
exposed group reported that they had a medical condition compared to 25% in the control 
group. The most commonly prevalent medical condition in the OMT group was hepatitis 
(41%), anxiety (23.5%), depression (20.6%), and asthma or allergies (11.8 %) whereas 
the most common conditions in the control group were asthma or allergies (15 %) and 
depression (10%). 
We did not observe specific differences in self-reported multivitamin or iron use during 
the period surrounding pregnancy based on the OMT exposure. Twenty two percent of 
the subjects reported using multivitamin more than 4 times a week in the month before 
their last menstrual period. Although a higher proportion of the controls (35% vs 14.7%) 
were using multivitamins during the month before their last menstrual period compared 
to OMT group, the difference was not statistically significant (p=0.10). At the time 
surrounding the first interview i.e. after the subjects had discovered that they were 
pregnant, the prevalence of regular multivitamin users (more than 4 times a week) had 
increased to 90% in both the study groups. This value increased to 93% in the OMT 
group and 100% in the controls by the time of the second interview. A relatively lower 
proportion of the study subjects reported using multivitamin containing iron compared to 
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regular multivitamins. At visit 1, 25% of the healthy controls and 18% of OMT users 
reported that they used iron supplements. 
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Table 7: Demographics characterisitcs of the study sample 
 Total sample 
(N=54) 
OMT 
Exposed 
(n=34) 
Controls  
(n=20) 
p-
value 
Age (years) 27.0 ± 5.2 27.8 ± 5.2 25.7 ± 5.1 0.16* 
 N (%) n (%) n (%)  
Hispanic 35 (64.8) 24 (70.6) 11 (55.0) 0.37ǂ 
Marital Status       0.02ǂ 
 Single/ Separated/ 
Divorced 
30 (55.6) 23 (67.6) 7 (35.0)  
 Married/ Unmarried 
(cohabitating) 
24 (44.4) 11 (32.3) 13 (65.0)  
Race       0.14ǂ 
 White 49 (90.7) 29 (85.3) 20 (100.0)  
 Others 5 (9.3) 5 (14.7) 0 (0.0)  
Education level       0.02ǂ 
 High-school or less 33 (61.1) 25 (73.5) 8 (40.0)  
 Some college or higher 21 (38.9) 9 (26.5) 12 (60.0)  
Employed 17 (31.5) 8 (23.5) 9 (45.0) 0.13ǂ 
Health insurance        0.01ǂ 
 Medicaid 43 (79.6) 31 (91.2) 12 (60.0)  
 Other 11 (20.4) 3 (8.8) 8 (40.0)  
*student’s t-test, unequal variances 
ǂfisher exact test, r x c contingency table 
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Table 8: Physical charactersitics, reproductive characteristics, alcohol and tobacco use in 
the study population 
 Total 
Sample 
(N=54) 
OMT 
Exposed 
(n=34) 
Controls 
(n=20) 
p-
value 
Pre-pregnancy weight (lb.) 148.5 ± 32.3 148.2 ± 29.5 148.8 ± 37.4 0.95* 
BMI (kg/m2) 26.0 ± 5.9 25.9 ± 5.6 26.2 ± 6.6 0.85* 
Total number of pregnancies 2.8 ± 1.8  3.4 ± 2.0  1.9 ± 0.9 <0.01* 
Gestational age at first 
interview (weeks) 
23.2 ± 7.1 21.9 ± 6.7 25.3 ± 7.5 0.10* 
 N (%) n (%) n (%)  
Weight status (BMI)    1.00ǂ 
 <=24.9 32 (60.4) 20 (60.6) 12 (60.0)  
  >=25.0 to <=29.9 11 (20.7) 7 (21.2) 4 (20.0)  
  >=30.0 10 (18.9) 6 (18.8) 4 (20.0)  
Presence of any medical 
condition 
27 (50.0) 
 
22 (64.7) 
 
5 (25.0) 
 
0.01ǂ 
 Hypertension 1 (1.8) 1 (2.9) 0 (0.0)  
 Seizure disorder 2 (3.7) 2 (5.8) 0 (0.0)  
 Thyroid disorder 3 (5.5) 2 (5.8)   1 (5.0)  
 Asthma or allergies 7 (12.9) 4 (11.8) 3 (15.0)  
 Hepatitis 14 (25.9) 14 (41.2) 0 (0.0)  
 Depression 9 (16.7) 7 (20.6) 2 (10.0)  
 Anxiety 9 (16.7) 8 (23.5) 1 (5.0)  
 Migraine headaches 4 (7.4) 4 (11.8) 0 (0.0)  
 Others 5 (9.3) 4 (11.8) 1 (5.0)  
Unplanned pregnancy 34 (62.9) 25 (73.5) 9 (45.0) 0.04ǂ 
Primigravida 15 (27.8) 7 (20.6) 8 (40.0) 0.06ǂ 
Multivitamin Use     
 During LMP(>4 times a 
week) 
12 (22.2) 5 (14.7) 7 (35.0) 0.10ǂ 
 At V1 49 (90.7) 29 (85.3) 20 (100.0) 0.14ǂ 
   Frequency (n=49)    1.00ǂ 
    At least 4 times a week 44 (89.8) 26 (89.7) 18 (90.0)  
 At V2 51 (94.4) 32 (94.1) 19 (95.0) 1.00ǂ 
   Frequency (n=51)    1.00ǂ 
    At least 4 times a week 48 (96.0) 29 (93.5) 20 (100.0)  
Multivitamin (Iron) use 11 (20.7) 6 (18.2) 5 (25.0) 0.72ǂ 
*student’s t-test, unequal variances 
ǂfisher exact test, r x c contingency tables 
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Substance and alcohol use in the OMT group 
Table 9 shows the prevalence of substance use in the subjects in the OMT group at first 
interview (V1) and at the follow up interview (V2). The information on prevalence of 
substance and alcohol use for the healthy control is not presented because the subjects in 
healthy control group were designed to have no exposure to substances such as opioids 
and tobacco. Another characteristic of the healthy control group was absence or minimal 
alcohol exposure during the period surrounding the last menstrual period and overall 
pregnancy. The obvious lack of such exposures in the healthy control group gave us 
sufficient leverage to exclude them from the substance, alcohol and tobacco exposure 
table.    
Overall there was a decreasing trend of substance abuse from V1 to V2. The most 
commonly used substance was marijuana (after excluding methadone and 
buprenorphine). At V1 29% of the subjects had reported some use of marijuana but at V2 
it had decreased to 14.7%. Other commonly used substances were pain relievers, heroin, 
benzodiazepine, methamphetamine and barbiturates. All of these substances also showed 
a decreased trend in use from V1 to V2. There were 15 (44%) methadone users at V1 
who used it daily. There were 19 (56%) buprenorphine users at V1. One of the subjects 
had shifted from using methadone to using buprenorphine at V2. 
Table 10 shows the frequency of alcohol use and tobacco users in the OMT group. The 
results in this table have been calculated after the exclusion of subjects based on the 
alcohol intake criteria. Alcohol use in the OMT group reveals a decreasing trend from 
calendar 1 to calendar 2.  Calendar 1 is the 29 day period surrounding the last menstrual 
period and calendar 2 is the 29 day period surrounding the first interview. The total 
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drinking day on average during the calendar 1 was 2.8 days with an average amount of 
alcohol consumed per day amounting to 1.0 units of absolute alcohol per drinking day. 
These values decreased to an average 0.2 drinking days in calendar 2 with average 
amount of alcohol consumed in that period totaling 0.04 units of absolute alcohol per 
drinking day. Table 10 also shows the prevalence of tobacco use in the pregnant women 
on OMT. Ninety one percent of the subjects reported that they had smoked but only 50% 
were regularly smoking at visit1. At visit 1 the proportion of current smokers had 
decreased to approximately 41%. 
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Table 9: Frequency of self reported substance use in the OMT group at enrollement and 
at visit 2 (n=34) 
Substance abuse 
in OMT group  
Almost 
everyday 
Once a 
week 
Once 
every 2-3 
weeks 
Once a 
month 
Occasion
ally (less 
than 
monthly) 
Any use 
Marijuana       
Visit 1 3 (8.8) 2 (5.9) 0 (0.0) 1 (2.9) 4 (11.8) 10 (29.4) 
Visit 2 1 (2.9) 2 (5.9) 0 (0.0) 1 (2.9) 1 (2.9) 5 (14.7) 
Heroin       
Visit 1 4 (11.8) 1 (2.9) 0 (0.0) 1 (2.9) 1 (2.9) 7 (20.6) 
Visit 2 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Methamphetamine       
Visit 1 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3 (8.8) 3 (8.8) 
Visit 2 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Methadone       
Visit 1 15 (44.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 15 (44.1) 
Visit 2 14 (41.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 14 (41.2) 
Buprenorphine       
Visit 1 17 (50.0) 1 (2.9) 0 (0.0) 1 (2.9) 0 (0.0) 19 (55.9) 
Visit 2 20 (58.8) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 20 (58.8) 
Opioid analgesics       
Visit 1 7 (20.6) 1 (2.9) 0 (0.0) 1 (2.9) 1 (2.9) 10 (29.4) 
Visit 2 1 (2.9) 0 (0.0) 0 (0.0) 1 (2.9) 1 (2.9) 3 (8.8) 
Benzodiazepines       
Visit 1 3 (8.8) 1 (2.9) 0 (0.0) 0 (0.0) 2 (5.9) 6 (17.6) 
Visit 2 0 (0.0) 1 (2.9) 0 (0.0) 0 (0.0) 1 (2.9) 2 (5.9) 
Barbiturates       
Visit 1 0 (0.0) 1 (2.9) 0 (0.0) 0 (0.0) 1 (2.9) 2 (5.8) 
Visit 2 1 (2.9) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.9) 
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Table 10: Alcohol and tobacco use in the OMT group 
 TLFB Calendar1* TLFB Calendar2* 
 Mean SD Mean SD 
Alcohol use     
Total drinking days 2.8 4.3 0.2 0.8 
Total drinks (Absolute alcohol) 13.5 22.6 0.3 1.3 
Average amount of alcohol per drinking day 1.0 1.6 0.04 0.2 
Tobacco use Visit 1 Visit 2 
 n (%) n (%) 
Current smoker 17 (50.0) 14 (41.2) 
Ever smoker 31 (91.2) - 
 
*TLFB Calendar 1: 29 day period surrounding last menstrual period, TLFB calendar 2: 
29 day period surrounding visit 1 interview. 
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Analysis of energy intake and sources of energy  
Descriptive statistics and the results of a t-test to assess the difference in energy intake 
per day and sources of energy in OMT subjects and controls is presented in Table 11. The 
average total energy intake in the study sample was 2234.8 ± 992.2 Kcal/day. Average 
carbohydrate intake per day was 284.8 ± 123.7g, average protein intake was 84.9 ± 38.4g 
and average fat intake was 100.2 ± 47.2g in the study population. The primary source of 
energy in the study population was carbohydrate 48.7%. The crude analysis of difference 
in energy intake between the groups showed that subjects in OMT group had higher 
intake in calories compared to controls (2469.6 ± 1091.7g vs 2105.6 ± 766.9, p=0.15), 
but the difference was not statistically significant. There was no significant difference in 
consumption of carbohydrates (304.9 ± 130.0g vs 250.5 ± 106.6g, p=0.1), protein (86.2 ± 
43.4g vs 82.5 ± 29.1g, p=0.71) and total fat (105.3 ± 52.9g vs 91.6 ± 35.2g, p=0.25) in 
OMT group compared to subjects in controls. We observed that significantly higher 
percentage of energy was derived from protein in controls compared to the OMT subjects 
(16 ± 3.6% in controls vs 14 ± 2.5% in OMT, p=0.03) 
After log transformation of energy intake, no significant difference in energy intake was 
observed (p=0.24). The difference in energy-adjusted macronutrient (protein, fat and 
carbohydrates) intake in OMT group vs control group was analyzed and it was found that 
the adjusted total protein intake was significantly higher in the control group (35.0±1.1 vs 
40.1±9.1 gm per 1000 Kcal per day, p=0.03). We did not observe any difference in 
energy-adjusted total carbohydrate intake (p=0.45) and energy-adjusted total fat intake 
(p=0.14).The results are shown in Table 12. 
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The results of the MANOVA which tested the effect of OMT exposure on composite 
energy-adjusted carbohydrate, protein and total fat are shown in Table 13. The null 
hypothesis that the vectors of means are equal for the two groups was rejected (p=0.02) 
which showed that there is an effect of OMT status on energy-adjusted macronutrient 
intake.  
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Table 11: Description of energy intake and sources of energy by study group 
 Total study 
sample (N=54) 
OMT Exposed 
(n=34)  
Controls (n=20)   
 Mean S.D. Mean S.D. Mean S.D. p-
value* 
Total Energy intake 
(Kcal/day) 
2334.8 992.2 2469.6 1091.7 2105.6 766.9 0.15 
Total Protein intake 
(g/day) 
84.9 38.4 86.2 43.4 82.5 29.1 0.71 
Total Fat intake (g/day) 100.2 47.2 105.3 52.9 91.6 35.2 0.25 
Total Carbohydrate intake 
(g/day) 
284.8 123.7 304.9 130.0 250.5 106.6 0.10 
Percentage of energy 
from: 
       
Fat 38.5 5.31 38.1 5.2 39.2 5.6 0.45 
Protein 14.8 3.1 14.0 2.5 16.0 3.6 0.03 
Carbohydrate 48.7 6.9 49.6 7.0 47.1 6.7 0.19 
Sweets 13.1 10.8 13.8 9.9 11.9 12.5 0.55 
Alcohol 0.7 2.3 1.0 2.8 0.05 0.1 0.05 
*students t-test, unequal variance 
Table 12: Analysis of log-transformed energy intake and energy-adjusted micronutrient 
intake by study group 
 Total study 
sample (N=54) 
OMT Exposed 
(n=34) 
Controls (n=20)  
 Mean SD Mean SD Mean SD p-
value** 
Log-transformed 
Energy Intake 
7.7 0.4 7.7 0.4 7.6 0.3 0.24 
Adjusted total 
protein intake* 
36.9 7.7 35.0 1.1 40.1 9.1 0.03 
Adjusted total fat 
intake * 
42.8 5.9 42.3 5.8 43.6 6.2 0.45 
Adjusted total 
carbohydrate* intake 
121.7 17.4 124.0 17.5 117.7 16.7 0.14 
*Adjustment based on total energy intake, adjusted macronutrient = (macronutrient 
intake/ total energy intake) * 1000, units: g per 1000 Kcal. 
**students t-test, unequal variance 
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Analysis of the effect of socio-demographic characteristics on energy and macronutrient 
intake 
The result of the Hotelling’s test (equivalent of MANOVA when the independent 
variables is binary) examining the effect of OMT exposure, ethnicity (Hispanic or not), 
race (White or others), employment, marital status (married/cohabitating vs single, 
divorced, separated), education level (high-school or less vs some college or more) and 
insurance status (Medicare or others) are shown in Table 13. We observed that ethnicity 
(p=0.03), race (0.04) and marital status (0.05) had a significant effect on the composite 
energy-adjusted macronutrient intake.  
Table 13: Hotelling’s T2 (Test of effect of OMT exposure and other covariates on 
macronutrient intake) 
Predictors p-value 
OMT exposure 0.02 
Ethnicity 0.03 
Race 0.04 
Employment 0.07 
Marital status 0.05 
Education level 0.06 
Insurance 0.44 
The dependent variables in the MANCOVA were energy-adjusted carbohydrate, fat and 
protein intake. 
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Multivariate analysis for energy and macronutrient intake 
The results of the MANVCOVA to examine the effect of OMT on macronutrient intake 
(energy-adjusted carbohydrate, fat and protein intake) after controlling for ethnicity, 
employment status, marital status, education level, age and BMI (categorical) are shown 
in Table 14. Race was not used in the analysis because none of the subjects in control had 
identified themselves as others. The effects of OMT exposure on the composite 
macronutrient intake was not observed when controlled for other covariates (p=0.27). 
However, we observed a significant effect of ethnicity on composite energy-adjusted 
macronutrient intake (p=0.02). We also observed a borderline significant effect of 
employment status on composite energy-adjusted macronutrient intake (p=0.07). This 
could possibly mean that being Hispanic would be attributable to having a different 
composite mean on the dependent variables compared to being non-Hispanic. 
The results for the multivariate regression analysis based on the MANCOVA model are 
shown in Table 15. No significant effect of OMT exposure on any of the three outcomes 
of interest (energy-adjusted carbohydrate, proteins or fats) was observed. However, 
ethnicity had a significant impact on energy-adjusted carbohydrate intake; Hispanic 
subjects on average consumed 11.9g/1000 Kcal more than non-Hispanics after 
controlling for other factors (p=0.02). Similarly, employment was found to have 
significant impact on energy-adjusted protein intake. After controlling for all the other 
variables, subjects who were employed consumed 5.8g/1000 Kcal more proteins than 
their unemployed counterparts (p<0.01).  
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Table 14: MANCOVA (Test of effect of OMT exposure after adjustment for ethnicity 
employment, marital status, education level age at V1 and BMI on macronutrient intake) 
Predictors p-value 
OMT exposure 0.27 
Ethnicity 0.02 
Employment 0.07 
Marital status 0.33 
Education level 0.24 
Age at V1 0.62 
BMI (categorical) 0.90 
The dependent variables in the MANCOVA were energy-adjusted carbohydrate, fat and 
protein intake. 
 
Table 15: Multivariate regression: Analysis of the effect of OMT exposure on energy-
adjusted macronutrient intake after controlling for covariates 
 Energy-adjusted 
carbohydrate intake 
(g/1000Kcal/day) 
Energy-adjusted 
protein intake 
(g/1000Kcal/day) 
Energy-adjusted total 
fat intake 
(g/1000Kcal/day) 
 β coefficient  
(95% CI) 
p-
value 
β coefficient  
(95% CI) 
p-
value 
β coefficient  
(95% CI) 
p-
valu
e 
OMT exposure 4.4 (-6.5, 15.3) 0.42 -2.6 (-7.1, 1.9) 0.26 -1.5 (-5.6, 2.5) 0.45 
Ethnicity 11.9 (1.5, 22.4) 0.02 -2.1 (-6.4, 2.3) 0.34 -2.6 (-6.5, 1.3) 0.19 
Employment -6.1 (-16.5, 4.2) 0.24 5.8 (1.5, 10.2) <0.01 0.4 (-4.2, 3.5) 0.84 
Marital status 9.0 (-1.4, 19.5) 0.08 -1.1 (-5.5, 3.3) 0.61 -2.7 (-6.6, 1.2) 0.16 
Education level -2.5 (-14.4, 9.1) 0.67 3.5 (-1.3, 8.3) 0.15 0.3 (-4.0, 4.6) 0.88 
BMI category       
  25 - 29.9 -0.3 (-12.2, 11.6) 0.95 1.2 (-3.8, 6.2) 0.62 -0.7 (-5.1, 3.7) 0.75 
  30 >= -3.5 (-15.7, 8.6) 0.56 1.85 (-3.2, 6.9) 0.73 -1.2 (-3.4, 5.7) 0.61 
Age at V1 -0.1 (-1.0, 0.8)  0.79 0.2 (-0.2, 0.6) 0.24 -0.02 (-0.4, 0.3) 0.90 
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Analysis of micronutrient intake from diet in pregnant women by study group 
Unadjusted analysis of the micronutrient intake from diet in pregnant women in our study 
is shown in Table 16. We observed that the intake of beta-carotene was significantly 
lower in OMT group compared to controls exposed group (2936.3 ± 2549.4 mcg vs 4898 
± 3825.7 mcg, p=0.05). We did not observe any significant difference in micronutrient in 
the OMT group versus the controls. However, we observed that there was slightly higher 
but statistically insignificant intake of several of several micronutrients such as thiamin 
(p=0.45), riboflavin (p=0.27), vitamin B6 (p=0.36), vitamin B12 (p=0.33), vitamin C 
(p=0.59), vitamin D (p=0.59), vitamin E (p=0.71), iron (p=0.54), folate (p=0.80), and 
choline (p=0.42) in the OMT group.  
 Analysis of energy-adjusted micronutrient intake showed opposite trends in the results 
compared to the unadjusted analysis (Table 17). OMT group had lower intake of Vitamin 
A, thiamin, riboflavin, vitamin B6, vitamin B12, beta-carotene, vitamin C, vitamin D, 
vitamin E, iron, folate and choline per 1000 Kcal energy compared to controls. However, 
these differences were not significant except for vitamin A (388.4 ± 142.5 vs 485.7 ± 
188.4 RAE/1000 Kcal, p=0.05), beta-carotene (1271.3 ± 1153.9 vs 2386.3 ± 1750.8 
mcg/1000 Kcal, p=0.01), vitamin E (4.5 ± 0.8 vs 5.5 ± 1.9 a-TE/1000 Kcal, p=0.03) and 
folate (245.5 ± 62.3 vs 290.5 ± 66.9 DFE/1000 Kcal, p=0.01). Despite these individual 
differences for specific micronutrients, the MANOVA model showed that OMT exposure 
did not have a statistically significant effect on the difference in means of composite 
energy-adjusted micronutrients (p=0.10)  
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Table 16: Micronutrient intake by study groups 
Micronutrient 
intake from diet 
Total Study sample 
(N=54) 
OMT Exposed 
group (n=34) 
Controls (n=20)  
Mean SD Mean SD Mean SD p-
value* 
Vitamin A (mcg-
RAE) 
939.23 421.9 907.7 409.9 992.9 447.2 0.48 
Thiamin (mg) 1.8 0.8 1.9 0.8 1.7 0.7 0.45 
Riboflavin (mg) 2.3 0.9 2.4 1.0 2.1 0.7 0.27 
Vitamin B6 (mg) 2.2 0.8 2.3 0.8 2.1 0.7 0.36 
Vitamin B12 (µg) 5.4 2.7 5.7 2.8 5.0 2.5 0.33 
Beta-carotene (µg) 3662.9 3195.0 2936.3 2549.4 4898.0 3825.7 0.05 
Vitamin C (mg) 183.0 132.3 190.3 134.4 170.6 131.1 0.59 
Vitamin D (mcg) 5.8 3.9 6.1 4.0 5.5 3.8 0.59 
Vitamin E (a-TE) 11.1 4.7 10.9 4.8 11.4 4.6 0.71 
Iron (mg) 16.6 7.1 17.0 7.6 15.9 6.2 0.54 
Folate (DFE) 591.6 226.9 585.8 232.0 601.6 223.4 0.80 
Choline (mg) 353.5 158.4 365.4 181.3 333.3 110.4 0.42 
* Student’s t-test 
 
Table 17: Micronutrient in study group after adjustment for total energy intake 
Energy-adjusted 
micronutrient* 
intake from diet 
Total Study sample 
(N=54) 
OMT Exposed 
group (n=34) 
Controls (n=20)  
Mean SD Mean SD Mean SD p-
value ǂ 
Vitamin A (mcg- 
RAE) 
424.4 166.2 388.4 142.5 485.7 188.4 0.05 
Thiamin (mg) 0.8 0.1 0.7 0.1 0.8 0.1 0.10 
Riboflavin (mg) 1.0 0.3 1.0 0.2 1.1 0.3 0.66 
Vitamin B6 (mg) 1.0 0.2 0.9 0.2 1.0 0.2 0.62 
Vitamin B12 (µg) 2.4 1.1 2.4 0.9 2.5 1.4 0.75 
Beta-carotene (µg) 1684.3 1491.1 1271.3 1153.9 2386.3 1750.8 0.01 
Vitamin C (mg) 76.8 44.2 76.3 48.4 77.6 37.3 0.91 
Vitamin D (mcg) 2.6 1.6 2.5 1.2 2.8 2.1 0.62 
Vitamin E (a-TE) 4.9 1.4 4.5 0.8 5.5 1.9 0.03 
Iron (mg) 7.3 1.9 7.1 2.0 7.7 1.6 0.25 
Folate (DFE) 262.1 67.1 245.5 62.3 290.5 66.9 0.01 
Choline (mg) 155.1 37.9 150.8 34.7 162.5 42.8 0.3 
*Adjustment based on total energy intake, adjusted micronutrient = (micronutrient intake/ 
total energy intake) * 1000, units per 1000 Kcal. 
ǂ Student’s t-test 
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Analysis of the effect of socio-demographic factors on dietary micronutrient intake 
A MANOVA that included all of the micronutrient variables being tested except beta-
carotene (beta-carotene is used in calculation of total vitamin A intake) as the dependent 
variable was used to analyze the effect of ethnicity, race, marital status, education level, 
employment status and insurance type. We observed that insurance type (p=0.02) and 
marital status (p=0.01) had significant effect on the difference of means in the 
micronutrients being tested. Our analysis showed that ethnicity (p=0.63), race (p=0.40), 
employment status (p=0.64), and education level (p=0.44) did not have an effect on the 
composite energy-adjusted micronutrient intake. The results of the individual tests are 
shown in Table 18. 
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Table 18: Hotelling’s T2 (Test of effect of OMT exposure, ethnicity, race, employment, 
marital status, education level and insurance on energy-adjusted dietary micronutrient 
intake) 
Predictors p-value 
OMT exposure 0.10 
Ethnicity 0.63 
Race 0.40 
Employment 0.64 
Marital status 0.01 
Education level 0.44 
Insurance 0.02 
The dependent variables are energy-adjusted Vitamin A, B1, B2, B6, B12, C, D, E, beta-
carotenes, iron, folate and choline. 
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Multivariate analysis for energy-adjusted dietary micronutrient intake 
The results of the MANCOVA test which examined the effect of OMT on energy-
adjusted composite measure of micronutrient intake after adjustment for marital status, 
insurance, age at V1 and BMI (categorical) is shown in Table 19. After adjustment for 
the covariates, OMT status was not observed to have an effect on the composite 
micronutrient intake (p=0.19). 
The results of the multivariate regression on energy-adjusted vitamin A, vitamin E, folate 
and choline based on the MANCOVA model are shown in Table 20. These 
micronutrients were selected because significant difference was observed between the 
OMT and the control group in the energy-adjusted analysis. Although statistically 
significant difference in between the groups was not observed for choline, it was included 
in the multivariate regression because of its clinical importance. No significant effect of 
OMT exposure was seen on vitamin A intake (p=0.12). OMT subjects had a lower intake 
of vitamin E on average by -0.9 a-TE/1000 Kcal per day (95% CI:-1.8, -0.1, p=0.03) 
compared to controls after controlling for other factors. In addition, folate intake in OMT 
group was 45.9 DFE/1000 Kcal (95% CI: 4.6, 87.1, p=0.03) lower on average compared 
to healthy controls after controlling for other factors. No significant effect of OMT 
exposure on choline intake was observed (p=0.38). 
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Table 19: MANCOVA (Test of effect of OMT exposure after adjustment for marital 
status, insurance, age and BMI on adjusted micronutrient intake) 
Predictors p-value 
OMT exposure 0.19 
Marital status 0.07 
Insurance  0.42 
Age at V1 0.01 
BMI (categorical)  0.38 
The dependent variables are energy-adjusted Vit A, B1, B2, B6, B12, C, D, E, iron, folate 
and choline 
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Table 20: Multivariate regression: Analysis of the effect of OMT exposure on energy-adjusted micronutrient intake after controlling 
for covariates 
 Energy-adjusted 
Vitamin A intake (mcg-
RAE/1000Kcal/day) 
Energy-adjusted  
Vitamin E intake  
(a-TE/1000Kcal/day) 
Energy-adjusted folate 
intake 
(DFE/1000Kcal/day) 
Energy-adjusted  total 
choline intake 
(mg/1000Kcal/day) 
 Β-coefficient 
(95% CI) 
p-
value 
Β-coefficient 
(95% CI) 
p-
value 
Β-coefficient 
(95% CI) 
p-
value 
Β-coefficient 
(95% CI) 
p-
value 
OMT exposure -82.0  
(-189.4, 24.9) 
0.12 -0.9  
(-1.8, -0.1) 
0.03 -45.9 
(-87.1, -4.6) 
0.03 -10.9  
(-36.1, 14.2) 
0.38 
Marital status -20.4 
(-121.5, 80.6) 
0.68 0.2  
(-0.6, 1.0) 
0.59 -8.9 
(-47.8, 29.9) 
0.694 -6.7 
(-30.5, 17.0) 
0.57 
Insurance type -79.2 
(-214.3, 55.8) 
0.24 -0.3 
(-1.3, 0.8) 
0.60 -15.5  
(-67.4, 36.4) 
0.42 -12.6 
(-44.4, 19.2) 
0.42 
BMI category         
25 – 29.9 37.7 
(-80.6, 156.0) 
0.64 1.2  
(0.2, 2.1) 
0.01 43.1 
(-2.4, 88.6) 
0.06 -0.1 
(-27.9, 27.6) 
0.99 
30>= -54.2 
(-174.1, 65.8) 
0.36 0.3 
(-0.6, 1.2) 
0.49 -22.5 
(-68.6, 23.6) 
0.33 -15.9 
(-44.1, 12.3) 
0.26 
Age at V1 2.33  
(-6.8, 1.5)  
0.6 0.04  
(-0.03, 0.1) 
0.26 1.4 
(-2.1, 4.9) 
0.42 0.9 
(-1.2, 3.1) 
0.37 
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Difference in intake of supplementary micronutrients among OMT exposed and controls 
The results of the analysis comparing intake of dietary supplements (vitamin A, thiamin, 
riboflavin, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, iron and folate) are 
shown in Table 21. No significant difference in micronutrient intake was observed among 
OMT user and control group (all p>0.05). We observed borderline statistical difference in 
iron intake (23.3 ± 21.3 vs 36.4 ± 30.4 mcg, p=0.09). A MANOVA conducted to evaluate 
the effect on composite multivitamin supplement did not generate results because of 
multicollinearity between the micronutrients in the supplements which signals that these 
micronutrients were highly likely to have come from a single supplement. 
  
70 
 
Table 21: Differences in intake of micronutrient supplementation in pregnant women in 
OMT group compared to controls 
Micronutrient intake 
from supplements 
OMT Exposed Controls p-value* 
Mean SD Mean SD  
Vitamin A (mcg-RAE) 1304.6 484.5 1478.6 848.3 0.40 
Thiamin (mg) 1.9 2.5 1.9 2.4 0.90 
Riboflavin (mg) 2.1 2.5 2.1 2.4 0.90 
Vitamin B6 (mg) 2.0 1.4 2.1 1.4 0.88 
Vitamin B12 (µg) 5.9 3.6 6.1 3.5 0.87 
Vitamin C (mg) 88.9 128.9 97.8 128.1 0.80 
Vitamin D (mcg) 353.8 134.2 384.3 153.6 0.46 
Vitamin E (a-TE) 22.6 24.7 25.8 31.2 0.69 
Iron (mg) 23.3 21.3 36.4 30.1 0.09 
Folate (DFE) 631.9 352.6 704.0 358.5 0.47 
*student’s t-test 
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Comparison of dietary intake in study subjects to recommended dietary allowances. 
The results of this analysis comparing dietary intake among study participants to EAR is 
shown in Table 22. Carbohydrate EAR intake levels were met by 95% of the controls and 
91% of the OMT exposed pregnant women. Protein intake levels were met by 75% of the 
healthy controls and 73% of the OMT exposed pregnant women. Analyzing the 
micronutrient intake levels excluding the dietary supplements we found that a significant 
proportion of our study subjects were deficient in vitamin E, iron, folate and choline. 
Vitamin E EAR levels were only met by 45% of the controls and 35% of the OMT 
exposed pregnant women. Similarly, iron EAR levels were only met by 15% of the 
controls and 23.5% of the OMT exposed group, folate intake levels were only met by 
55% of the healthy controls while 56% of the OMT exposed group met the requirements 
and choline intake levels was met by 15% of the controls compared to 23.5% in the OMT 
exposed group. It should also be noted that mean values of dietary iron and choline intake 
were also lower than the specified EAR. After accounting for intake of multivitamins and 
supplements, over 90% of the pregnant women in both group met the requirements for 
almost all of the micronutrients that were being analyzed. There were a few subjects in 
the OMT groups that did not meet the EAR requirements, but this could be due to 
inadequate or no micronutrient supplementation in those individuals. 
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Table 22: Proportion of study subjects meeting the EAR with and without micronutrient 
supplementation 
 Met EAR based on diet 
alone 
p-value 
(exact-
test) 
Met EAR based on diet 
and supplementations 
p-value 
(exact-
test) OMT 
exposed 
n (%) 
Controls 
n (%) 
OMT 
exposed 
n (%) 
Controls 
n (%) 
Macronutrients       
Carbohydrates 31 (91.2) 19 (95.0) 0.52 - - - 
Proteins 25 (73.5) 15 (75.0) 0.58 - - - 
       
Micronutrients       
Vitamin A (mcg-RAE) 28 (82.3)    16 (80.0) 0.55 34 (100) 19 (95.0) 0.37 
Thiamin (mg) 28 (82.3) 19 (95.0) 0.23 33 (97.0) 20 (100.0) 1.00 
Riboflavin (mg) 32 (94.1) 19 (95.0) 1.00 34 (100.0) 20 (100.0) - 
Vitamin B6 (mg) 28 (82.3) 16 (80.0) 1.00 33 (97.1) 20 (100.0) 1.00 
Vitamin B12 (mcg) 33 (97.1) 19 (95.0) 1.00 34 (100.0) 20 (100.0) - 
Vitamin C (mg) 27 (79.4) 18 (90.0) 0.45 33 (97.1) 20 (100.0) 1.00 
Vitamin D (mcg) 7 (20.6) 1 (5.0) 0.23 30 (88.2) 18 (90.0) 1.00 
Vitamin E (a-TE) 12 (35.3) 9 (45.0) 0.56 30 (88.2) 19 (95.0) 0.64 
Iron (mg) 8 (23.5) 3 (15.0) 0.51 30 (88.2) 19 (95.0) 0.64 
Folate (DFE) 19 (55.8) 11 (55.0) 1.00 32 (94.1) 19 (95.0) 1.00 
Choline (mg)* 8 (23.5) 3 (15.0) 0.51 - - - 
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CHAPTER 5: DISCUSSION 
 
This section includes the discussion of the results followed up by recommendations for 
future research. The section begins with the discussion on the effect of OMT exposure on 
energy and micronutrient intake. Then, results of dietary intake based on socio-
demographic factors are discussed. Finally, strengths, limitations, recommendations for 
future research and conclusions are presented.  
Discussion of the demographic characteristics of the study participants 
There were some typical characteristics of the subjects in the OMT exposed group. A 
significant proportion were Hispanics, unmarried, had lower education level, 
unemployed, had Medicare for their health insurance and significant proportion (64.7%)  
of the subjects had reported medical conditions such as hepatitis, anxiety and depression. 
The demographic characteristics of the OMT exposed study group mirrors several other 
studies which included patients with substance abuse 59,84. This observation shows that 
the patients on OMT are significantly different than those who were included as healthy 
controls. It is important to consider these differences in the light of the analysis. The 
impact of ethnicity, education level, employment and medical condition could all 
possibly have a strong effect on dietary intake. The impact of these factors might 
contribute to poor nutritional status in people undergoing OMT along with the effect of 
OMT itself. We have controlled for some of these factors in our multivariate analysis, but 
the cumulative impact of these socio-demographic characters on dietary intake cannot be 
undermined. 
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Effect of OMT exposure on energy intake 
There was no significant difference in energy intake between the OMT group and 
controls (p=0.15) although the average intake in the OMT group was higher by 250 Kcal 
per day compared to the controls. The difference in energy intake in our study subjects 
was lower than that reported by the previous study59. The unadjusted analysis showed 
that the bulk of the energy was derived from carbohydrates. The energy-adjusted analysis 
also showed that total protein intake was lower in OMT group as compared to controls 
(p=0.03). This means that if an average subject consumed 2000 Kcal per day, the controls 
intake would be 80g per day while for OMT exposed it would be 70 g per day. This 
difference of an average of 10g per day per 2000 Kcal diet could have a significant 
implications during pregnancy. This difference that we observed in energy-adjusted 
protein intake was observed only in the crude analysis. Although the MANOVA analysis 
on energy adjusted composite macronutrients showed that there was some effect of OMT, 
We did not observe any effects after controlling for age, BMI, ethnicity, employment, 
marital status and education level. We did not observe significant effect of OMT 
exposure on energy-adjusted protein intake after we adjusted for the same covariates even 
though an association was observed in the energy adjusted analysis.   
Although significant difference in energy intake in pregnant women on OMT was not 
observed, the result that the average energy intake OMT group was slightly higher than 
that in the controls is in agreement with previous studies 58,59,84. However, the magnitude 
of difference that we observed was lower (difference of approximately 250 Kcal between 
groups) than that reported by Tomedi et al (2012) (difference of approximately 800Kcal 
between groups). This could have been possible due to a variety of reasons. Firstly, the 
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characteristics of the study population could have played a significant role in energy 
intake. The participants in the Tomedi et al (2012) study were recruited from Philadelphia 
which has a significantly different social and cultural aspect compared to subjects in New 
Mexico. Also, majority of the study participants in that study were non-Hispanic whites 
compared to a majority of Hispanic subjects in this study. Second, since our study 
consists of pregnant women who were recruited from clinics associated with UNM 
hospital, it is highly likely that there is some surrounding social structure around the 
participants that lead to overall better health and diet compared to the subjects in the 
previous studies.  It is to be noted that the average energy intake in the controls this study 
and the study by Tomedi et al are almost similar at approximately 2100 Kcal per day. 
Statistical significance in that study could have been primarily driven by the high energy 
intake level of approximately 3000 Kcal per day observed in the subjects in the OMT 
group. Similarly, Tomedi et al (2012) also observed significant difference in energy 
percentage of energy derived from proteins. It is also important to note that that 
difference was found to be not significant after controlling for other covariates. These 
similarities in our results support the finding that OMT exposure is associated with 
difference in energy and macronutrient intake and the possible reason that statistical 
significance was not observed could be small sample size. 
Effect of OMT exposure on micronutrient intake 
The analysis of difference in mean intake of micronutrient in our study groups showed 
that there was lower intake of beta-carotenes in the OMT group. Although not 
statistically significant, it was observed that for most micronutrients the intake level was 
higher in the OMT group in the crude analysis. However, the difference in energy-
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adjusted micronutrient intake was opposite of the difference we observed in crude 
micronutrient intake. This study found significant deficiencies in several important 
micronutrients among OMT patients. Specifically, lower intake of beta-carotenes, 
vitamin E, and folate was observed in OMT patients. In addition, there was a trend 
towards lower intake of vitamin A in OMT patients of borderline statistical significance. 
The difference in intake of folates in between OMT patients and controls was particularly 
significant. A 45 DFE/1000 Kcal difference in between OMT and controls is a difference 
of approximately 90 DFE per day if we assume a subject consumes 2000 Kcal a day on 
average. The estimated average requirement of folate during pregnancy is 520 DFE per 
day, hence a difference of 90 DFE is significant considering the recommendations. This 
difference is particularly important because studies have consistently shown that 
deficiency of folate is associated with neutral tube disorders 33,36,43. The differences in 
vitamin A and vitamin E intake was relatively minor compared to the difference that was 
observed in the intake of folate. However, these micronutrients play an important role in 
the growth and development of fetus. Significant deficiencies in vitamin A could lead to 
pre-eclampsia 45and there are reports of miscarriage due to deficiencies in vitamin E 45. 
These results shows that the nutrient density in pregnant women on OMT is lower than 
those in controls. The implication of these findings could be significant in promoting 
healthier diet in pregnant women on OMT. Promoting a healthier diet in these individuals 
would not only involve them to cut down on their energy intake but also to improve their 
micronutrient intake from other sources. The findings of our study are reflected in the 
previous study by Tomedi et al (2012), where it was found that after adjustment for total 
energy intake per day, pregnant women on OMT had significantly less intake of folate, 
77 
 
vitamin C and vitamin E after controlling for energy intake59. Similar observation in this 
study certainly reinforces our hypothesis that subjects in the OMT group have lower 
intake of micronutrients in their diet. 
Socio-demographic characteristics and their association with energy and micronutrient 
intake  
The results of the multivariate regression showed that there was some effect of 
demographic factors on the intake of energy-adjusted carbohydrate and proteins. We 
observed that Hispanics were likely to have more carbohydrate intake compared to non-
Hispanics by an average of 11.9 g/1000 Kcal/day. This would round up to an average of 
24 g of carbohydrate more per day if we consider that the average subject consumed 2000 
Kcal per day. Similarly, it was observed that the subjects who were employed had a 
significantly higher intake of proteins compared to the unemployed subjects by an 
average of 5.8 g/1000 Kcal/day. This would be an average of 10 g a day if we consider 
the average subject consumed 2000 Kcal per day.  
There are several factors that might have caused these differences. Consider the higher 
carbohydrate intake in Hispanics. It could be driven by their dietary patterns and food 
groups that might be rich in carbohydrates 117. The observation of the difference in 
carbohydrate intake could be possibly related other sociological factors associated with 
the ethnicity such as employment rates, education level, marital status all of which could 
have a possible effect on dietary patterns. Similarly, the observation that higher protein 
intake in the employed subjects after controlling for other covariates demonstrates that 
there is a strong tendency in subjects with a job to have a diet rich in protein. Usually 
higher income is associated with employment and studies have reported higher adherence 
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to dietary guidelines in subjects with higher income 118. This could be a possible reason 
that we observed higher protein intake in subjects who were employed. Although there 
are several other factors that might result the opposite such as lesser time for food 
preparation and consumption of fast food that could lead to poor diet qualities. This 
study, however, did not observe such effect. We might also consider the fact that 
employment rates are associated with higher education level. The multivariate analysis 
did not produce a significant effect of education level on adjusted protein intake, but a 
trend was observed that employment and higher education level were associated with 
higher protein intake and lower carbohydrate intake.  
In the intake of micronutrients, specific trends based on socio-demographic 
characteristics was not observed. The Hotelling’s test showed that insurance type and 
marital status showed some effect on composite intake of energy-adjusted micronutrients. 
However, these effect were not observed in the multivariate analysis, There could be 
various possible explanation for the lack of difference in our observations. Firstly the 
FFQ ensures that ethnicity specific food groups are not missed which eliminates the risk 
of ethnicity being a factor in determining differences in dietary intake. Also, the 
population is derived from a specific study area whereby the effect of cultural variety on 
dietary patterns is reduced. Small sample size and a large variance in the intake of 
micronutrients could have been another reason that significant differences due to the 
socio-demographic characteristics were not observed. 
Effect of alcohol consumption on energy intake 
According the design of the parent study, healthy controls had to be very light alcohol 
users before pregnancy and abstain from alcohol use after the last menstrual period. 
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However, in the OMT group, subjects with exposure to alcohol were not excluded. Thus, 
the effect of alcohol use on nutritional status could not be controlled for in multivariate 
analysis given that healthy controls had zero prevalence. The study minimized this 
limitation by excluding subjects from the OMT groups who were heavy drinkers. Among 
OMT users, 35% had reported some drinking around their LMP, but only 6% of the OMT 
subjects reported some alcohol exposure during the 1 month period before their first 
interview. The amount of alcohol consumption in those subjects who reported alcohol 
was also significantly lower because we excluded subjects who had reported consuming 
more than 1.5 units of absolute alcohol per day around their LMP. As seen in Table 10 
the average amount of drinking during the 30 days period before enrollment was 0.08 oz. 
per drinking day (equivalent to 0.04 units of absolute alcohol/drinking day). Thus, it can 
be argued that there would be minimal effect of alcohol on dietary patterns in our study 
population. 
Biological mechanisms affecting dietary pattern in pregnant women on OMT 
There are several speculations about the biological mechanisms that affect dietary 
patterns in opioid using pregnant women. American Dietetic Association states that 
substance abusers could have an accelerated nutritional requirement to higher levels than 
required on a regular basis 119. This could suggest that the body would develop a 
compensatory mechanism to increase energy and nutrient intake to balance the energy 
deficit. This could be a possible explanation of higher energy intake in subjects on OMT. 
A systematic review published in 1994 associated substance use to bulimia 120, that 
subjects who use substance are more likely to binge eat. Studies also point towards 
reward mechanism, impulsivity and vulnerability to impulse related disorders in 
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substance using subjects 121. Although this study is not examining eating disorders in the 
subjects, the modulation of the reward pathway by opioids and a compensatory response 
by the body to account for energy deficit in substance abusing patients could be possible 
explanations in the increased dietary intake in subjects on OMT. 
Dietary intake of study participants in relation to estimated average requirements 
Comparison of dietary intake of the pregnant women in our study to the EAR showed 
that the pregnant women in both groups were not meeting the requirements of some 
micronutrients through their diet alone. The observation that the study participants’ diet 
was especially deficient in vitamin E, folate and iron demonstrates the need for dietary 
supplementation. After supplementation, pregnant women in both group had adequate 
intake of iron and folate. Also concerning is the significantly large proportion of the 
study subjects in both group not meeting the adequate intake requirements for choline. 
The adequate intake suggested by IOM is 450 mg/day 42, but the mean intake in both the 
study groups is approximately 350 mg/day with only 23% of the subjects in OMT group 
and 15% in the controls consuming the adequate amount. Many studies have shown the 
importance of choline in human diet, especially during pregnancy 50,81,82. This deficiency 
of choline in such significant proportion of the population may contribute to 
developmental disorders in the growing fetus. Since choline is not primarily 
supplemented in multivitamins, other sources of choline should be sought after. The 
observed results calls for more attention to supplementation with choline by diet 
modification and intake of multivitamins which contain choline. The dietary intake of 
Vitamin D was remarkably low in both groups without supplementation. This deficiency 
in their diet is less concerning because most of the vitamin D requirements for the body 
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comes from exposure to sun rays 122. Dietary supplementation of vitamin D was able to 
control for this deficiency in diet. It is important to acknowledge that supplementation 
with vitamin D could be essential because studies show that significant proportion of the 
US population is deficient in vitamin D123. Based on the results of comparing dietary 
intake of pregnant women in our study and the EAR, it can be stated that a significant 
proportion of the subjects were not taking satisfactory levels of micronutrients in their 
diet. This highlights the importance of micronutrient supplementation in pregnancy. The 
communication of this finding can enable health care providers to promote healthy diet in 
pregnant women. 
Limitations 
The results of this study should be interpreted in the light of some limitations. The study 
is limited by sample size. The limited sample size makes it difficult to observe smaller 
differences that could have been possibly present. We had calculated that a sample size of 
65 with 40 subjects on the OMT group and 25 on the HC group had a 90% power to 
detect a difference in energy intake of 150 Kcal per day. However, our sample size was 
slightly smaller with only 34 subjects in the OMT group and 20 subjects in the controls. 
Contributing to this problem was a greater than expected variability in energy and some 
other nutrients within each study group.  
Another limitation is the potential for confounding effect of alcohol, tobacco, other 
substances and maternal medical conditions. These risk factors could not be controlled 
for in the multivariate analyses given that the controls were selected to be life-long 
abstainers from drugs and, non-smokers.  A sub-group analysis on these factors within 
the OMT group is statistically possible, but it would still be limited by the sample size. 
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With respect to chronic medical conditions, the study groups were very unbalanced for 
viral hepatitis (64% in OMT vs. 0% in health controls), as expected in opioid-dependent 
population. Other medical conditions were also either incomparable or had low 
prevalence thus restricting our analysis. The variation in the type of medical condition 
also was a limiting factor in determining if medical condition played any role in the 
subjects’ nutrition. 
The generalizability of the study might be limited since the cultural and ethnic heritage of 
the state of New Mexico is significantly different from the general US population. The 
interpretation of the results of this study in the context of other geographical and ethnic 
region could be inaccurate. Recall bias could affect the results of the dietary analysis. The 
FFQ questionnaires are usually designed to control for these factors but recall data than 
spans a year could be imprecise. FFQ presents an average value of dietary intake over the 
course of the year. Pregnancy is a time which is characterized by several physical, 
reproductive and dietary changes over a span of 9 months. This could have a significant 
impact on the reliability of the FFQ. Although FFQ is considered better than the 24 hour 
recall method, several recall interviews during the period surrounding pregnancy could 
have produced better precision in dietary intake of our subjects rather than a single 
assessment after delivery. 
There are several other factors that were not addressed in our study. Biomarkers could be 
an important marker of absorption of nutrients. The food frequency questionnaire only 
provides us information on what the pregnant women were consuming, it does not 
provide any information on absorption and metabolism of food. If there are any metabolic 
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or mal-absorptive symptoms in study subjects, the biomarker analysis would play a vital 
role in identifying if there are any deficiencies in nutrient intake. 
Another limitation of this study is that it focuses on quantitative data. The absence of data 
that specifically pertains to the individuals’ knowledge on food groups, nutrition 
requirements, attitudes and behaviors regarding diet, family support and help during 
pregnancy could be important driving factors affecting dietary intake. Since it is an 
individual and his/her conceptions and cravings that drive dietary habits, information on 
such factors could be crucial in interpreting the results of effect of OMT exposure in 
pregnant women. 
Strengths 
The strengths of our study is the initial design. A cohort study is a powerful tool to 
measure multiple effects based on an initial exposure. Although the primary purpose of 
the study delves in early indices of prenatal alcohol exposure, the robust study design and 
wealth of information gives us high quality data on the subjects who are enrolled in the 
study. The recruitment of the study subjects from specific clinic (Milagro) that provides 
for pregnant women who are undergoing opioid maintenance therapy ensured that there is 
no misclassification of patients. The patients recruited in OMT group specifically 
received OMT through the clinic. This enabled precise classification of subjects into 
OMT exposed or controls. Further, screening using urine biomarkers of opioid or 
substance abuse, alcohol biomarkers in serum and blood, along with biomarkers of 
tobacco consumption confirmed if a patient is abusing other drugs. This ensured that the 
researchers are not relying on self-report alone to recruit the subjects and it is a 
significant strength of this study. The initial interview process during prenatal visits and 
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the subsequent follow up around the time of delivery provided adequate time to collect all 
relevant information regarding the study. This system of collection of information on 
different time points allowed the study to track changes of multivitamins, alcohol, 
tobacco and substance use over the period of pregnancy.  The study also boasts of a 
double entry system to maximize quality assurance and minimize missing data. 
Future directions and policy implications 
Future studies should focus on evaluating patients’ knowledge regarding diet, food 
habits, choices, behaviors, cultural attributes and attitudes towards eating healthy food. 
Our study added to the increasing evidence that there are significant and important 
deficiencies in dietary intake among opioid dependent pregnant women. The effect of 
OMT might be difficult to disentangle from the effect of socio-demographic and other 
environmental characteristics (unstable housing, financial insecurities, involvement of the 
legal system, lack of social support and peer pressure etc.) on dietary habits. These 
direction could be multi-directional and quite complex. Additional work is needed to 
further examine the effect and interplay of these factors on dietary intake.  
The results that were observed gives significant information that can be applied towards 
improving the diet of pregnant women in general. It was observed that there was 
significant deficiencies regarding iron, folate and choline which need supplementation. 
Specific supplementations regarding choline are available which could be recommended 
to pregnant women. It is imperative that prenatal care providers emphasize the 
importance of micronutrient supplementation as the results of this study explicitly states 
that micronutrient supplementation are required to meet the dietary recommendation of 
several micronutrients.  
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Future direction in regards to research and analysis could also include stratification of 
OMT group by methadone or buprenorphine use. Also, the effect of other substances 
such as marijuana, heroin, benzodiazepines that were concomitantly used by the study 
subjects can be controlled for in the analysis of dietary patterns. Also other analysis could 
be performed that accounted for alcohol and tobacco use. It would also be interesting to 
see if any medical condition played a role in affecting dietary patterns in pregnant 
women. Future research could be the examination of pregnancy outcomes based on the 
dietary patterns in OMT group versus the controls. When pregnancy outcomes are 
associated with dietary patterns, we could possibly have results that further promote the 
fact that diet plays a significant role in healthy pregnancy, all the more in pregnancy 
involving use of opioid maintenance therapies. Such research would provide an immense 
strength to the argument that healthy diet is necessary for healthy nutrition as dietary 
patterns could be associated with health outcomes. 
The communication of this finding can inform health care practitioners and pregnant 
women to choose healthier nutrient rich diet which could be beneficial during their 
pregnancy. Intervention that focus on dietary change should focus on several domains of 
behavior change. A review by Malek et al (2015) summarizes 34 studies that evaluate the 
factors which influence women’s dietary choices during their pregnancy124.  The review 
suggested that perceptions regarding benefit and risk of healthy nutrition, individual 
beliefs, self-efficacy knowledge, financial standing and environment of food all played a 
vital role in determining the food choices during pregnancy. The review also started that 
key factors that influenced change in diet were received from their care providers. The 
review also highlighted the need of other methods such as persuasive communication, 
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automated feedback and modification of food culture and environment that enabled 
healthier food preferences in pregnant women. This review highlights the fact that 
promotion of healthy nutrition does not fit a single avenue. There are several programs 
such as the Special Supplemental Nutrition Program for Woman, Infants and Children 
(WIC), Supplemental Nutrition Assistance Program (SNAP) which can help provide 
assistance to low income pregnant women to get access to healthy foods. Along with 
such programs addition of a dietician in substance use treatment program, social support 
and awareness about the importance of healthy nutrition could be paramount in 
promoting healthy diet in pregnant women. Through an effective collaboration between 
health care workers, family, supplemental government program and educational agencies, 
healthy diet and pregnancy can be ensured. 
Conclusion 
This study demonstrates that there are significant deficiencies in macro and micronutrient 
intake in opioid dependent pregnant women compared to controls. It was observed that 
pregnant women on OMT consumed lower proteins on average compared to controls. 
Also their caloric intake was higher than controls but the results was not statistically 
significant. In addition to OMT, socio demographic characteristics such as ethnicity and 
employment were significant predictors of energy-adjusted carbohydrate and protein 
intake respectively. Further, the diet in the OMT groups had lower nutrient density than 
controls. Multivariate analysis demonstrated that pregnant women on OMT had 
significantly lower intake of vitamin E and folate after controlling for marital status, 
insurance type, BMI and maternal age. Our results were in agreement with previous 
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research on several avenues such as higher energy intake and low nutrient density in the 
OMT group. 
Comparison of dietary intake in the study subjects with estimated average requirements 
demonstrated that diet alone was insufficient to meet the requirements of several 
micronutrients. The results showed that supplementation with multivitamins was 
necessary to meet the requirements, especially for iron and folate. Choline, which is 
increasingly being studied as an essential micronutrient, was observed to be deficient in a 
significant proportion of the study population. Thus supplementation of choline through 
diet modification or dietary supplements should be recommended by healthcare workers 
to pregnant women to ensure that they receive adequate amounts during pregnancy. 
Additional research with a larger sample size along with qualitative information 
regarding health behaviors surrounding diet and nutrition should be another step in future 
research. These analyses when coupled with pregnancy outcomes data can provide 
further support towards healthy nutrition during pregnancy. Promoting healthy nutrition 
is important because of its role in preventing premature births, low birth weights and 
birth defects. Diet of a pregnant mother is certain to affect the fate of the growing fetus. 
The effects on the child could possibly be chronic and might affect the future of the baby. 
Hence, it is paramount that the results of this research in nutrition in pregnant women is 
communicated well to pregnant mothers, their families and health care workers such that 
effective measures can be taken to promote a healthy diet and a healthy pregnancy.  
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